Ankylosing spondylitis, ICD10

M13_ANKYLOSPON_ICD10

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M45 Cause of death: ICD-10 — M45 2 out of 7 registries used, show all original rules.	4038
4. Check minimum number of events None	4038
5. Include endpoints None	4038
6. Filter based on genotype QC (FinnGen only)	3664

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF3
Parent code in ICD-10: M45-M49
Name in latin: Spondylarthritis/spondylitis ancylopoetica

NAME	M13_ANKYLOSPON_ICD10
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M45
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M45
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Ankylosing spondylitis, ICD10 based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Ankylosing spondylitis, strict definition

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3664	1752	1912
Unadjusted period prevalence (%)	0.75	0.62	0.88
Median age at first event (years)	43.84	42.10	45.44

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3807: Matched controls
38070

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P01BA02

ATC

hydroxychloroquine; oral

5.5

312.6

696

1498

L04AB05

ATC

certolizumab pegol; parenteral

42.5

309.5

186

M45

ICD-10 Finland

Ankylosing spondylitis

73484.1

307.7

3776

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

79.2

307.7

3120

2065

L04AC10

ATC

secukinumab; parenteral

38.2

307.7

220

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

48.0

307.7

1360

436

L04AX03

ATC

methotrexate; systemic

15.6

307.7

1767

1997

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

30.0

307.7

332

121

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

13.2

307.7

1183

1261

L04AB04

ATC

adalimumab; parenteral

30.5

307.7

891

377

S01FA04

ATC

cyclopentolate; ophthalmic

22.3

307.7

272

131

S01BA04

ATC

prednisolone; ophthalmic

19.6

307.7

458

264

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

32.4

307.7

620

227

L04AA13

ATC

[U] leflunomide

13.0

307.7

392

332

L01BA01

ATC

methotrexate; systemic

20.1

307.7

801

497

M01AH01

ATC

celecoxib; oral

4.3

307.7

1198

3671

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

10.8

307.7

987

1198

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

47.4

307.7

1399

461

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

1118.6

307.7

401

H02AB06

ATC

prednisolone; systemic

3.9

307.7

2572

13181

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

57.7

307.7

700

148

L04AB01

ATC

etanercept; parenteral

39.1

307.7

654

201

A07EC01

ATC

sulfasalazine; oral, rectal

73.8

307.7

2814

1408

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

24.3

307.7

1127

648

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

58.8

307.7

626

127

L88

ICPC

Rheumatoid/seropositive arthritis

18.9

307.7

916

629

L04AB06

ATC

golimumab; parenteral

58.1

307.7

456

S01BA01

ATC

dexamethasone; ophthalmic

13.3

307.7

559

487

H20.1

ICD-10 Finland

Chronic iridocyclitis

27.9

307.7

292

113

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

2842.8

288.0

275

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

322.4

266.9

268

S01FA02

ATC

scopolamine; ophthalmic

23.6

266.5

193

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

9.8

249.5

300

331

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

6.2

248.9

459

823

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

36.6

237.2

148

L04AA11

ATC

[U] etanercept

40.9

227.8

138

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.0

226.8

1550

7069

M13.9

ICD-10 Finland

Arthritis, unspecified

4.5

215.4

599

1527

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.9

214.8

754

2279

M01AC06

ATC

meloxicam; systemic, rectal

2.9

214.6

1816

9225

WZA10

NOMESCO Finland

Extensive medical or dental certificate

11.8

206.1

214

191

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

82.2

195.8

104

H02AB07

ATC

prednisone; oral

3.5

192.1

801

2699

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

32.0

191.2

124

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

12.5

186.2

186

156

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

6.9

179.5

287

442

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

165.9

2117

12657

M01AH05

ATC

etoricoxib; oral

2.8

163.2

2876

19961

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

10.3

153.8

175

178

M01CB01

ATC

sodium aurothiomalate; parenteral

12.9

153.7

150

121

N02AX02

ATC

tramadol; systemic, rectal

2.4

148.8

1971

11788

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

37.7

148.8

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.5

148.2

580

1857

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.8

147.4

237

366

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

6.4

139.0

238

392

M01AH02

ATC

rofecoxib; oral

3.2

135.6

630

2235

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.3

133.4

367

916

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.2

133.2

291

602

L04AA17

ATC

[U] adalimumab

32.2

131.4

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

7.8

129.0

182

243

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

7.5

128.3

188

262

M01AX01

ATC

nabumetone; oral

5.1

127.8

283

592

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.1

126.7

227

391

L04AX01

ATC

azathioprine; systemic

4.5

126.4

330

790

M01AB01

ATC

indometacin; systemic, rectal

3.7

122.4

416

1207

TNG10

NOMESCO Finland

Puncture of knee

10.1

121.9

140

144

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

6.3

121.0

209

347

K50.8

ICD-10 Finland

Other Crohn disease

7.5

118.0

173

241

L04AA01

ATC

[U] ciclosporin

9.0

112.9

141

162

M01AB55

ATC

diclofenac, combinations; oral

3.9

112.0

358

994

XX9XE

NOMESCO Finland

Other ultrasound examination

11.1

104.6

112

104

A07EC02

ATC

mesalazine; oral, rectal

3.7

103.4

358

1048

A02BC02

ATC

pantoprazole; systemic

2.2

102.8

2781

20872

UJF32

NOMESCO Finland

Coloscopy

2.2

101.4

1118

5968

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.1

100.7

1678

10491

NF1AA

NOMESCO Finland

Hip X-ray examination

3.2

100.1

436

1475

M01AE02

ATC

naproxen; oral, rectal

2.1

95.9

2371

16974

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

95.7

686

3023

M01AX17

ATC

nimesulide; oral

2.3

95.3

992

5154

ZX140

NOMESCO Finland

Intra articular

10.7

94.8

104

100

K50.0

ICD-10 Finland

Crohn disease of small intestine

6.5

93.6

155

246

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

10.4

92.0

103

102

4AB02, ,

NOMESCO Finland

17.9

91.4

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

88.6

1483

9175

K50.9

ICD-10 Finland

Crohn disease, unspecified

6.5

87.2

145

231

H20

ICD-10 Finland

Iridocyclitis

12.0

86.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

85.5

551

2298

M01CB03

ATC

auranofin; oral

12.9

84.7

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.9

83.8

258

695

L04AB02

ATC

infliximab; parenteral

11.1

83.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

82.4

1871

12747

M05BA04

ATC

alendronic acid; oral

3.2

80.2

339

1122

A02BC03

ATC

lansoprazole; oral

2.0

79.3

1146

6676

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.5

79.0

201

469

A07EA06

ATC

budesonide; oral, local oral

3.9

78.7

246

669

ZX120

NOMESCO Finland

Intravenous

2.7

77.8

450

1773

H02AB04

ATC

methylprednisolone; systemic

2.4

77.3

645

3024

M46.0

ICD-10 Finland

Spinal enthesopathy

29.2

73.4

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.1

73.3

332

1143

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

72.3

567

2580

H57.1

ICD-10 Finland

Ocular pain

3.6

72.1

255

754

L04AC13

ATC

ixekizumab; parenteral

17.3

70.5

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

8.9

70.4

101

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.1

70.2

317

1089

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

67.7

484

2108

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

67.6

1142

6952

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

27.4

67.4

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

67.2

503

2237

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

8.4

66.4

106

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.5

66.3

447

1893

H15.1

ICD-10 Finland

Episcleritis

5.8

66.1

123

219

M03BX02

ATC

tizanidine; oral

1.8

65.4

2548

19930

298, ,

Kela drug reimbursment

15.2

64.8

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.1

64.7

763

4087

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

22.6

64.2

K50.1

ICD-10 Finland

Crohn disease of large intestine

6.4

64.2

108

174

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.1

64.0

136

273

3029

Kela drug reimbursment

Upadacitinib

14.1

62.2

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.7

61.6

202

567

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

60.1

1675

11772

R4110

NOMESCO Finland

Physiotherapy

1.9

59.8

1107

6890

M25.5

ICD-10 Finland

Pain in joint

1.8

59.3

1412

9477

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.9

59.1

303

1115

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

10.0

57.8

L40.5

ICD-10 Finland

Arthropathic psoriasis

4.8

57.3

131

280

M02.1

ICD-10 Finland

Postdysenteric arthropathy

20.7

56.6

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

18.2

56.0

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

4.7

55.6

130

283

S01BA07

ATC

fluorometholone; ophthalmic

5.3

55.5

114

222

4AA12, ,

NOMESCO Finland

12.7

55.5

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

7.1

55.1

119

M54.5

ICD-10 Finland

Low back pain

1.7

54.7

1522

10610

M35.7

ICD-10 Finland

Hypermobility syndrome

5.4

54.1

108

205

S01BC03

ATC

diclofenac; ophthalmic

4.5

54.1

136

314

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

117.8

53.9

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

8.1

53.8

RK220, ,

NOMESCO Finland

13.2

53.7

S01ED01

ATC

timolol; ophthalmic

4.0

53.1

153

392

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

52.4

1224

8102

N03AX16

ATC

[U] pregabalin

1.9

52.4

900

5437

M07.3

ICD-10 Finland

Other psoriatic arthropathies

6.1

52.2

152

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

6.5

52.0

133

H02AB08

ATC

triamcinolone; systemic

14.4

51.9

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

5.4

50.4

100

189

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.5

50.0

123

279

K51.5

ICD-10 Finland

Left sided colitis

3.5

50.0

179

532

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

50.0

1754

12912

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

49.6

509

2567

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

6.2

49.4

140

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.6

49.3

117

258

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

70.9

49.2

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

10.1

48.7

Z3226

NOMESCO Finland

Physiotherapist

1.9

48.6

704

4013

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

4.7

48.6

114

249

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

11.5

48.3

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

47.7

384

1752

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.5

46.3

167

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

6.9

46.2

104

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

46.2

336

1466

M01AB05

ATC

diclofenac; systemic, rectal

1.7

46.1

2561

20991

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

11.0

45.1

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

44.4

1099

7328

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.5

43.6

158

N06AA09

ATC

amitriptyline; systemic

2.3

43.3

365

1697

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.5

43.2

149

432

M01AC01

ATC

piroxicam; systemic, rectal

2.0

42.6

483

2521

L04AA44

ATC

[U] upadacitinib

14.8

42.5

A02BC05

ATC

esomeprazole; systemic

1.6

41.9

1505

10994

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

41.7

317

1408

NG1DA

NOMESCO Finland

X-ray of knees

4.3

40.9

107

255

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

40.5

283

1211

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

40.3

935

6100

A02BC01

ATC

omeprazole; systemic

1.7

40.0

955

6275

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.7

40.0

131

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.9

39.6

119

314

N02BE01

ATC

paracetamol; systemic, rectal

2.0

39.3

3353

30089

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

39.3

395

1968

S12.2

ICD-10 Finland

Fracture of other specified cervical vertebra

5.9

39.1

120

RK210, ,

NOMESCO Finland

14.0

39.1

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

6.9

38.2

A02BB01

ATC

misoprostol; oral

9.5

38.0

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.9

37.9

114

301

M54.8

ICD-10 Finland

Other dorsalgia

2.7

37.8

216

838

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

103.6

37.8

M01AB08

ATC

etodolac; oral

2.3

37.6

297

1340

K51.8

ICD-10 Finland

Other ulcerative colitis

4.3

37.5

229

J01MA02

ATC

ciprofloxacin; systemic

1.6

37.5

1380

10067

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

6.2

37.4

105

71490

ICD-8 Finland

Other specified forms of arthritis, Arthritis postinfectiosa NUD

13.6

37.4

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

36.8

346

1678

RT272, ,

NOMESCO Finland

13.1

36.6

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

8.9

36.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

35.6

1358

9958

J01DB01

ATC

cefalexin; oral

1.7

35.1

3128

27713

M13.8

ICD-10 Finland

Other specified arthritis

5.3

35.0

137

L04AK01

ATC

leflunomide; oral

6.3

34.7

N03AX12

ATC

[U] gabapentin; oral

1.8

34.5

611

3674

NF1DA

NOMESCO Finland

X-ray of hips

3.9

33.9

101

265

L99

ICPC

Musculoskeletal disease other

3.5

33.0

115

336

L02

ICPC

Back symptom/complaint

1.9

32.9

435

2384

UJF92

NOMESCO Finland

Capsular endoscopy

3.5

32.9

113

327

L04AF03

ATC

upadacitinib; oral

10.1

32.7

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.9

32.2

100

S01FA01

ATC

atropine; ophthalmic

9.2

32.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

32.0

173

653

N06AX21

ATC

duloxetine; oral

1.9

32.0

485

2779

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.6

31.7

165

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.5

31.4

108

313

SPAT1325

SPAT

Vaccination

1.6

31.3

1018

7153

K07.60

ICD-10 Finland

Snapping jaw

2.4

31.2

229

1000

M02AA07

ATC

piroxicam; topical

1.5

31.0

1167

8472

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.1

30.7

128

418

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.5

30.7

199

821

L04AD01

ATC

ciclosporin; systemic

3.6

30.5

103

295

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

30.5

1006

7086

K02.1

ICD-10 Finland

Caries of dentine

1.5

30.4

2292

19163

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.3

30.2

118

371

H20.8

ICD-10 Finland

Other iridocyclitis

6.8

30.1

M16.7

ICD-10 Finland

Other secondary coxarthrosis

5.9

30.1

N02AC04

ATC

dextropropoxyphene; oral

3.1

29.9

126

414

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.6

29.5

268

B01AB05

ATC

enoxaparin; parenteral

1.6

29.5

1033

7366

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

29.3

1354

10237

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

29.3

794

5331

NAJ12

NOMESCO Finland

Posterior reduction of fracture of cervical spine

37.4

29.3

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.3

29.0

173

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

28.8

844

5771

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

28.7

2547

21869

L04AC05

ATC

ustekinumab; parenteral

6.3

28.7

J01CA04

ATC

amoxicillin; systemic

1.6

28.6

3059

27339

L84

ICPC

Back syndrome without radiat pain

2.4

28.6

213

936

A07EA02

ATC

hydrocortisone; rectal

3.3

28.5

111

348

NDL52

NOMESCO Finland

Tenosynovectomy of hand

6.1

28.4

SFA10

NOMESCO Finland

One-surface restoration

1.5

28.3

2081

17197

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

9.3

28.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

27.8

313

1621

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

27.7

432

2492

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

9.8

27.7

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

27.5

832

5723

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.0

27.4

194

NA2AD

NOMESCO Finland

Thoracic spine CT examination

6.4

27.3

H26.2

ICD-10 Finland

Complicated cataract

4.2

27.3

173

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

8.4

27.0

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

26.9

2729

23892

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

6.6

26.8

F01

ICPC

Eye pain

2.8

26.6

137

504

M05BA07

ATC

risedronic acid; oral

3.5

26.6

263

A01

ICPC

Pain general/multiple sites

1.9

26.4

368

2047

P01AB01

ATC

metronidazole; oral, rectal

1.5

26.4

1387

10704

Z2221

NOMESCO Finland

Medical doctor

1.5

26.4

946

6753

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

6.8

26.3

SFA20

NOMESCO Finland

Two-surface restoration

1.4

26.3

2246

18972

Z50.1

ICD-10 Finland

Other physical therapy

2.3

26.3

200

887

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

8.4

26.1

M79.7

ICD-10 Finland

Fibromyalgia

2.6

26.1

151

590

J01FF01

ATC

clindamycin; systemic

1.5

26.0

974

7014

M02.8

ICD-10 Finland

Other reactive arthropathies

6.7

25.9

M01AE52

ATC

naproxen and esomeprazole; oral

2.7

25.9

138

517

71599

ICD-8 Finland

Arthritis, unspecified

9.7

25.9

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

25.8

706

4734

Z01.2

ICD-10 Finland

Dental examination

1.4

25.5

1726

13940

R03AC02

ATC

salbutamol; inhalant

1.4

25.4

1982

16417

NDG30

NOMESCO Finland

Fusion of wrist, total

7.1

25.4

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

25.4

193

856

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.7

25.2

125

R42

ICD-10 Finland

Dizziness and giddiness

1.6

25.0

742

5068

A07EA01

ATC

prednisolone; oral, rectal

7.2

25.0

R06.0

ICD-10 Finland

Dyspnoea

1.5

25.0

902

6437

S01ED51

ATC

timolol, combinations; ophthalmic

2.1

24.9

236

1145

L04AC07

ATC

tocilizumab; parenteral

8.5

24.9

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.9

24.7

191

E0000UV, ,

ATC

1.4

24.6

1455

11437

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

24.6

564

3617

Z3231

NOMESCO Finland

Registered nurse

1.5

24.5

916

6582

M79.6

ICD-10 Finland

Pain in limb

1.4

24.4

1580

12622

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

24.1

476

2933

J01FA06

ATC

roxithromycin; oral

1.4

24.1

1367

10653

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

23.8

374

2157

J01AA02

ATC

doxycycline; systemic

1.5

23.8

2787

24726

C10AC01

ATC

colestyramine; oral

2.9

23.8

112

393

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

7.0

23.7

L28

ICPC

Limited function/disability (L)

1.6

23.7

565

3656

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

23.5

967

7076

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

23.4

1312

10188

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

23.4

149

610

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

6.7

23.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

23.4

890

6409

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

23.4

472

2926

SPAT1202

SPAT

Intra-articular injection

3.0

23.2

102

344

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

23.1

332

1864

R51.80

ICD-10 Finland

Headache

1.6

23.0

583

3828

S01FA06

ATC

tropicamide; ophthalmic

24.8

23.0

D05AX52

ATC

calcipotriol, combinations; topical

2.1

23.0

213

1025

R50.9

ICD-10 Finland

Fever, unspecified

1.6

22.9

549

3558

M01AA01

ATC

phenylbutazone; systemic, rectal

84.0

22.7

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

22.6

827

5901

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.4

22.5

159

683

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

22.5

2047

17265

H26.3

ICD-10 Finland

Drug-induced cataract

5.7

22.4

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.3

22.4

258

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

45.3

22.3

A02BA02

ATC

ranitidine; systemic

1.6

22.3

591

3921

SFA30

NOMESCO Finland

Three-surface restoration

1.4

22.3

1566

12627

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

22.3

274

1461

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

22.2

826

5909

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

22.2

270

1435

H30.2

ICD-10 Finland

Posterior cyclitis

9.1

22.1

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.5

22.1

221

WZC30

NOMESCO Finland

Teaching

1.6

22.0

587

3900

L03

ICPC

Low back symptom/complaint

1.5

21.9

1046

7860

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

21.9

281

1519

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.5

21.8

138

564

S18

ICPC

Laceration/cut

1.4

21.5

1611

13108

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

21.5

496

3180

M48.0

ICD-10 Finland

Spinal stenosis

1.8

21.4

369

2185

RT271, ,

NOMESCO Finland

26.5

21.3

Z2446

NOMESCO Finland

Social worker

2.0

21.3

238

1227

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

21.0

1288

10113

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

21.0

1507

12158

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.3

21.0

155

679

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

20.8

304

1714

L04AC21

ATC

bimekizumab; systemic

30.2

20.5

D07AC01

ATC

betamethasone; topical

1.4

20.5

1260

9891

UKC02

NOMESCO Finland

Cystoscopy

1.6

20.5

487

3144

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

20.3

665

4622

L01

ICPC

Neck symptom/complaint

1.6

20.2

590

3997

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.3

20.2

224

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

20.1

915

6797

M54.2

ICD-10 Finland

Cervicalgia

1.8

20.0

318

1840

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

20.0

1687

13945

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

4.3

19.9

120

M06

ICD-10 Finland

Other rheumatoid arthritis

5.7

19.9

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.3

19.9

145

632

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

19.8

183

880

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

6.3

19.7

JF1BD

NOMESCO Finland

Very extensive small bowel CT

6.3

19.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

19.7

329

1930

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

15.4

19.7

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

19.6

1409

11331

G44.2

ICD-10 Finland

Tension-type headache

1.6

19.6

483

3142

K50

ICD-10 Finland

Crohn disease [regional enteritis]

6.4

19.6

SPAT1263

SPAT

Sampling

1.4

19.4

1361

10896

J01FA10

ATC

azithromycin; systemic

1.4

19.3

2062

17651

M01AH03

ATC

valdecoxib; oral

2.0

19.3

207

1052

WX002

NOMESCO Finland

Sedation and analgesia

1.5

19.2

598

4106

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

19.2

289

1644

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

19.2

531

3551

L17

ICPC

Foot/toe symptom/complaint

1.4

19.1

1020

7793

RS221, ,

NOMESCO Finland

3.5

18.9

189

ZXE00

NOMESCO Finland

One hour or less

1.4

18.9

1276

10145

RK250, ,

NOMESCO Finland

5.8

18.8

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

18.7

119

487

Z71.8

ICD-10 Finland

Other specified counselling

1.4

18.7

1206

9510

SPAT1153

SPAT

Removal of sutures

1.4

18.6

975

7416

D07XC01

ATC

betamethasone; topical

1.6

18.5

414

2629

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

18.3

606

4216

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.4

18.2

103

M46

ICD-10 Finland

Other inflammatory spondylopathies

44.2

18.2

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

18.2

461

3018

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

18.1

271

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.4

18.1

121

507

M19.2

ICD-10 Finland

Other secondary arthrosis

3.5

18.1

180

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.9

18.0

288

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

17.9

735

5335

N02BF02

ATC

pregabalin; oral

1.8

17.9

257

1440

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

5.5

17.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

17.8

312

1854

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

17.8

243

1340

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

17.8

453

2968

7202A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Sacro-iliitis, not elsewhere classified

66.9

17.7

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.6

17.7

159

N02AA05

ATC

oxycodone; systemic

1.5

17.6

531

3617

J01MA12

ATC

levofloxacin; systemic

1.5

17.6

582

4044

7209X

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Unspecified inflammatory spondylopathy

95.5

17.6

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.3

17.5

129

565

RF120, ,

NOMESCO Finland

3.8

17.4

142

D94

ICPC

Chronic enteritis/ulcerative colitis

4.4

17.3

RF410, ,

NOMESCO Finland

3.6

17.2

157

L01BB02

ATC

mercaptopurine; oral

3.3

17.2

201

R2110

NOMESCO Finland

Giving the first information

1.9

17.2

231

1268

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

17.2

125

545

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

17.2

1877

16007

D06BB04

ATC

podophyllotoxin; topical

1.9

17.1

210

1118

C03CA01

ATC

furosemide; systemic

1.5

17.1

742

5441

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

17.4

16.9

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

16.8

1857

15837

H02BX01

ATC

methylprednisolone, combinations; systemic

2.2

16.8

144

672

JF1AD

NOMESCO Finland

Small bowel CT

4.6

16.8

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

3.6

16.7

151

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

16.7

379

2414

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

4.9

16.6

H221, M084,

ICD-10 Finland

90.5

16.6

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

16.5

230

1276

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

7.3

16.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

16.5

163

804

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

16.5

2628

23637

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

16.4

1912

16416

N02BF01

ATC

gabapentin; oral

1.6

16.3

366

2324

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

16.3

336

2088

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

16.3

1047

8215

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

16.2

835

6308

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

16.2

755

5602

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

47.7

16.0

NA6CF

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with median intensity magnet

47.7

16.0

L34

ICPC

Musculoskeletal, Blood test

24.6

16.0

RF420, ,

NOMESCO Finland

3.3

15.8

186

M02AA10

ATC

ketoprofen; topical

1.5

15.7

496

3406

S01EC01

ATC

acetazolamide; systemic

2.9

15.7

266

L13

ICPC

Hip symptom/complaint

1.5

15.6

578

4102

R05

ICD-10 Finland

Cough

1.4

15.6

719

5322

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

11.7

15.5

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

15.5

180

941

J02AC01

ATC

fluconazole; systemic

1.3

15.4

1248

10132

WX320

NOMESCO Finland

Spinalanesthesy

1.4

15.4

768

5764

RS222, ,

NOMESCO Finland

3.6

15.3

136

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

15.3

651

4746

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.9

15.2

201

1098

J01DA01

ATC

[U] cefalexin

1.3

15.1

2118

18565

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

15.0

158

799

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

14.9

239

1384

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

6.5

14.9

ZXA00

NOMESCO Finland

Right side

1.4

14.9

768

5795

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

3.4

14.6

150

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

6.3

14.5

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.9

14.5

228

WX290

NOMESCO Finland

Other blockage of nerve

1.3

14.5

1780

15287

D01

ICPC

Abdominal pain/cramps general

1.5

14.4

411

2759

F02

ICPC

Red eye

2.0

14.4

150

755

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.6

14.4

308

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.6

14.2

129

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

14.1

958

7549

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

14.1

242

1430

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

14.1

324

2068

R60.0

ICD-10 Finland

Localized oedema

1.6

14.1

381

2527

R4120

NOMESCO Finland

Occupational therapy

1.8

14.0

225

1304

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

14.0

715

5377

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.7

14.0

266

N20.0

ICD-10 Finland

Calculus of kidney

2.5

14.0

330

J05AB01

ATC

aciclovir; systemic

1.4

14.0

704

5283

M05BA01

ATC

etidronic acid; systemic

10.1

13.9

R52.2

ICD-10 Finland

Other chronic pain

2.0

13.9

143

717

SDA03

NOMESCO Finland

Periodontal treatment

1.3

13.8

1464

12296

D07AD01

ATC

clobetasol; topical

1.5

13.6

533

3820

G47.3

ICD-10 Finland

Sleep apnoea

1.4

13.6

850

6610

4AB0X, ,

NOMESCO Finland

+∞

13.5

J99.8*M45

ICD-10 Finland

Respiratory disorders in ankylosing spondylitis

+∞

13.5

M01AB16

ATC

aceclofenac; oral

2.3

13.5

100

440

L20

ICPC

Joint symptom/complaint NOS

2.1

13.5

133

657

L04AA24

ATC

abatacept; parenteral

5.0

13.3

J05AB11

ATC

valaciclovir; oral

1.5

13.3

471

3306

291

Kela drug reimbursment

Tofacitinib

6.3

13.3

M02.3

ICD-10 Finland

Reiter disease

10.5

13.2

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.1

13.2

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

13.2

432

L86

ICPC

Back syndrome with radiating pain

1.8

13.1

209

1209

F29

ICPC

Eye symptom/complaint other

1.6

13.1

346

2281

J01FA09

ATC

clarithromycin; systemic

1.3

13.1

1029

8273

J20

ICD-10 Finland

Acute bronchitis

1.6

13.1

347

2290

NA6BG, ,

SPAT

5.5

13.0

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.9

13.0

204

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.5

12.9

128

ZXA05

NOMESCO Finland

Left side

1.4

12.9

693

5252

N06AX11

ATC

mirtazapine; oral

1.3

12.9

1123

9164

SPAT1301

SPAT

No procedures

1.3

12.8

914

7242

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

12.8

375

2533

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

5.8

12.7

M54

ICD-10 Finland

Dorsalgia

1.5

12.7

448

3144

-50

ICPC

Medication/prescr/renewal

2.1

12.6

126

625

13603

ICD-8 Finland

Other and unspecified infective and parasitic diseases, Morbus Reiter, syndroma urethro-oculo-articularis

70.1

12.6

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.8

12.6

H05AA02

ATC

teriparatide; parenteral

6.0

12.6

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

12.6

854

6714

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

12.5

310

2013

M17.5

ICD-10 Finland

Other secondary gonarthrosis

2.9

12.5

209

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.0

12.5

182

36402

ICD-8 Finland

Iritis, Iridocyclitis, uveitis chronica

20.1

12.4

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.3

12.4

136

L01CB

ATC

Podophyllotoxin derivatives

13.2

12.4

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

12.4

925

7373

R02

ICPC

Shortness of breath/dyspnoea

1.5

12.4

404

2790

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

12.3

247

1524

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

5.4

12.3

ZXA10

NOMESCO Finland

Bilateral

1.4

12.3

510

3692

114

Kela drug reimbursment

Glaucoma

1.7

12.2

207

1220

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

12.2

770

5983

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.8

12.2

195

1130

318

Kela drug reimbursment

Teriparatide

5.5

12.1

RT171, ,

NOMESCO Finland

12.4

12.1

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

12.1

942

7552

L15

ICPC

Knee symptom/complaint

1.4

12.1

794

6207

S01EA05

ATC

brimonidine; ophthalmic

2.5

12.0

282

L40.8

ICD-10 Finland

Other psoriasis

3.6

12.0

105

C07AB02

ATC

metoprolol; systemic

1.4

12.0

500

3619

R4180

NOMESCO Finland

Podiatric therapy

2.9

12.0

186

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

12.0

347

2335

SPAT1260

SPAT

Consultation of another employee

1.4

12.0

506

3673

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.0

12.0

181

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.3

11.9

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

11.9

887

7061

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

3.0

11.9

171

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

11.9

590

4407

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

11.8

216

1299

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

11.8

224

1362

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

5.9

11.8

TNF10

NOMESCO Finland

Puncture of hip joint

14.7

11.8

R52.9

ICD-10 Finland

Pain, unspecified

1.5

11.7

340

2288

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

8.9

11.7

KMAK, ,

NOMESCO Finland

1.3

11.7

1811

15856

R07.3

ICD-10 Finland

Other chest pain

1.5

11.7

335

2250

RT350, ,

NOMESCO Finland

16.4

11.6

4AB0M, ,

NOMESCO Finland

65.1

11.6

H221, M083,

ICD-10 Finland

65.1

11.6

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

11.6

700

5397

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

11.5

155

852

S21

ICPC

Skin texture symptom/complaint

1.4

11.5

461

3313

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

11.5

402

2814

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

11.4

344

7113L

ICD-9 Finland

Arthropathy associated with infections, Postdysenteric arthropathy[ENTEROARTHRITIS, USEAT NIVELET]

120.4

11.4

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.8

11.4

160

892

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

11.4

207

1244

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.4

1841

16184

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

11.3

1035

8470

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.0

11.3

124

637

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

3.6

11.3

100

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

11.2

1089

8983

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

11.2

126

654

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.9

11.2

172

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

5.6

11.2

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

5.6

11.2

N05CF01

ATC

zopiclone; oral

1.3

11.1

959

7783

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

11.1

136

726

-1, ,

NOMESCO Finland

1.3

11.1

1111

9199

N02AJ13

ATC

tramadol and paracetamol; systemic

2.3

11.1

362

ZY010

NOMESCO Finland

Hospital outpatient

1.7

11.0

187

1102

SFA00

NOMESCO Finland

Small restoration

1.4

11.0

473

3440

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

11.0

166

946

ZZH31

NOMESCO Finland

Bone allograft, small pieces

3.9

11.0

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

11.0

936

7585

M05BA06

ATC

ibandronic acid; systemic

2.9

11.0

174

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

10.9

975

7948

WX707

NOMESCO Finland

Fiberoscopic intubation

5.4

10.9

R11

ICD-10 Finland

Nausea and vomiting

1.6

10.9

263

1700

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

10.8

302

2015

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.5

10.8

255

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

10.8

167

959

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

10.8

242

1536

C08CA01

ATC

amlodipine; oral

1.3

10.8

1096

9086

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

10.8

380

2664

L16

ICPC

Ankle symptom/complaint

1.5

10.7

389

2742

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

17.8

10.7

ZXD05

NOMESCO Finland

Urgent procedure

1.3

10.7

945

7690

R35

ICD-10 Finland

Polyuria

1.7

10.6

209

1283

R31

ICD-10 Finland

Unspecified haematuria

1.5

10.6

292

1944

SPAT1255

SPAT

Intravenous administration of medicine

1.7

10.6

199

1207

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.1

10.6

454

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

10.6

117

604

XKD00

NOMESCO Finland

Uroflowmetry

1.4

10.5

443

3210

N20.1

ICD-10 Finland

Calculus of ureter

1.9

10.5

128

683

1008, ,

NOMESCO Finland

14.2

10.5

M03.2*A04.6

ICD-10 Finland

Postinfectious arthropathy in enteritis due to Yersinia enterocolitica

110.3

10.4

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

5.4

10.4

C07AB07

ATC

bisoprolol; oral

1.3

10.4

1404

12043

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.6

10.3

216

1347

7118L

ICD-9 Finland

Arthropathy associated with infections, Arthropathy associated with other infectious and parasitic diseases[ARTHRITIS POSTINFECTIOSA ALIA, USEAT NIVELET]

32.6

10.3

L04AA29

ATC

[U] tofacitinib

5.1

10.3

R01AD08

ATC

fluticasone; nasal

1.3

10.3

957

7833

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.3

10.3

329

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

10.3

260

1698

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

10.3

1127

9422

M48.9

ICD-10 Finland

Spondylopathy, unspecified

4.4

10.3

7168A

ICD-9 Finland

Other and unspecified arthropathies, Other specified arthropathy

18.8

10.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

10.2

343

2380

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

10.2

194

1181

9256

FHL

Synovectomy (knee 9311)

13.1

10.1

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.4

10.1

103

SPAT1229

SPAT

Assessment of need for aid

1.7

10.1

191

1160

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

10.1

639

4954

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.2

10.1

377

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.1

933

7631

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.1

10.1

410

A06AD11

ATC

lactulose; oral

1.5

10.0

361

2540

D07AC13

ATC

mometasone; topical

1.3

10.0

915

7468

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

4.5

10.0

TNE11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in sacroiliac joint

40.2

10.0

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.9

413

2985

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

9.9

651

5072

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.9

678

5315

M54.1

ICD-10 Finland

Radiculopathy

1.8

9.9

135

748

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

9.9

407

2939

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

9.8

208

1301

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.0

9.8

110

570

256, ,

Kela drug reimbursment

8.1

9.8

9273

FHL

Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe

4.9

9.8

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

4.7

9.8

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

9.5

9.7

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

9.7

779

6244

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

9.7

228

1464

N07CA01

ATC

betahistine; oral

1.7

9.7

190

1166

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

9.7

566

4334

A01AB09

ATC

miconazole; local oral

1.6

9.7

221

1410

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.1

9.6

132

S01FB01

ATC

phenylephrine; ophthalmic

55.1

9.6

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.9

9.6

159

S01EC04

ATC

brinzolamide; ophthalmic

2.0

9.6

478

RF421, ,

NOMESCO Finland

4.3

9.6

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

9.6

352

2487

G04CA02

ATC

tamsulosin; oral

1.3

9.5

667

5246

R06AE07

ATC

cetirizine; oral

1.2

9.5

1450

12573

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.8

9.5

R4110, ,

SPAT

1.4

9.5

396

2866

M01AC02

ATC

tenoxicam; systemic, rectal

1.9

9.4

120

650

M79.1

ICD-10 Finland

Myalgia

1.4

9.4

500

3769

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.9

9.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

9.4

831

6748

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

9.3

111

588

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.7

9.3

167

1001

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

9.3

330

2315

R01AD58

ATC

fluticasone, combinations; nasal

1.3

9.3

878

7187

C05AA08

ATC

fluocortolone; rectal, topical

1.4

9.2

395

2870

XCH00

NOMESCO Finland

Eye pressure measurement

1.8

9.2

135

764

E000001, ,

ATC

1.3

9.2

598

4649

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

9.2

909

7482

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.6

9.2

191

1191

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

9.2

926

7644

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

9.2

127

707

R5120

NOMESCO Finland

Preparation of an aid

2.1

9.1

426

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

9.1

1117

9437

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

9.1

337

2384

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

9.1

264

1778

H26.4

ICD-10 Finland

After-cataract

1.6

9.1

218

1407

S29

ICPC

Skin symptom/complaint other

1.3

9.1

619

4846

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

9.1

184

1140

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.8

9.1

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

9.0

378

2735

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.1

9.0

428

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

9.0

318

2229

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

7.0

9.0

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

9.0

431

3195

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

9.0

269

1825

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

8.9

141

816

M05.0

ICD-10 Finland

Felty syndrome

24.1

8.9

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

24.1

8.9

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

8.9

184

1146

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

8.9

214

1383

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.3

8.9

274

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

8.9

912

7541

M04AA01

ATC

allopurinol; systemic

1.4

8.8

335

2380

L85

ICPC

Acquired deformity of spine

8.0

8.8

R51

ICD-10 Finland

Headache

1.6

8.8

180

1118

71498

ICD-8 Finland

Other specified forms of arthritis, Alia definita

10.7

8.8

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

10.7

8.8

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

8.8

161

972

D82

ICPC

Teeth/gum disease

1.2

8.8

1280

11019

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

3.2

8.8

108

C08CA05

ATC

nifedipine; systemic

1.7

8.7

148

874

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

8.7

327

S01EE05

ATC

tafluprost; ophthalmic

2.0

8.7

454

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

8.7

308

2160

M54.3

ICD-10 Finland

Sciatica

1.6

8.7

185

1160

0108, ,

NOMESCO Finland

50.1

8.7

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

8.7

171

1052

U07

ICPC

Urine symptom/complaint other

1.5

8.7

234

1552

AA1AD

NOMESCO Finland

CT of head and brain

1.3

8.6

815

6663

M01AG01

ATC

mefenamic acid; oral

2.1

8.6

388

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

7.6

8.6

NFC00

NOMESCO Finland

Exchange of a loose part of prosthesis in hip joint

4.6

8.6

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.0

8.6

478

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

8.6

202

1299

M01CC01

ATC

penicillamine; oral

11.6

8.6

3641A

ICD-9 Finland

Disorders of iris and ciliary body, Chronic iridocyclitis

16.3

8.5

A07DA03

ATC

loperamide; oral

2.0

8.5

451

J01MA14

ATC

moxifloxacin; systemic

1.5

8.5

269

1844

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

8.5

714

5748

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

4.1

8.5

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

8.5

494

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

8.5

372

2715

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

8.5

1170

10003

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

8.5

358

RF210, ,

NOMESCO Finland

2.0

8.4

453

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.2

8.4

306

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

8.4

676

5410

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

8.4

247

1669

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

8.4

890

7379

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

8.4

147

877

WX212

NOMESCO Finland

Femoral plexus blockade

2.2

8.4

307

WZA00

NOMESCO Finland

Concise certificate

1.6

8.4

216

1419

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

6.7

8.3

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

8.3

738

5982

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.1

8.3

380

R53

ICD-10 Finland

Malaise and fatigue

1.3

8.3

783

6397

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

8.3

374

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.0

8.3

408

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

8.3

275

1905

N06AX16

ATC

venlafaxine; oral

1.4

8.3

463

3518

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

8.2

376

2762

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.1

8.2

375

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

8.2

408

3040

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.9

8.2

100

535

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

8.2

205

1338

NAJ22

NOMESCO Finland

Posterior reduction of fractrue of thoracic spine

7.5

8.1

WW200

NOMESCO Finland

Immunization

1.9

8.1

487

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

8.1

134

786

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

8.1

196

1268

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

4.8

8.1

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

8.1

685

5518

SPAT1251

SPAT

Organisation of medication

2.0

8.1

446

M07.2

ICD-10 Finland

Psoriatic spondylitis

33.4

8.1

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

8.0

277

1933

A46

ICD-10 Finland

Erysipelas

1.4

8.0

422

3173

TEG00

NOMESCO Finland

Punction of mandibular joint

8.9

8.0

L30.3

ICD-10 Finland

Infective dermatitis

1.8

8.0

112

626

R01AD12

ATC

fluticasone furoate; nasal

1.2

8.0

1066

9065

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

8.0

172

1082

R5599

NOMESCO Finland

Other rehabilitation service

2.0

8.0

441

XCK00

NOMESCO Finland

Perimetry

1.7

8.0

149

904

M81.4

ICD-10 Finland

Drug-induced osteoporosis

4.1

8.0

R05

ICPC

Cough

1.3

8.0

762

6233

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

8.0

288

2028

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

3.5

8.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

8.0

435

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.9

189

1219

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

7.9

177

1124

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

4.3

7.9

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

7.9

408

3059

M01AE51

ATC

ibuprofen, combinations; systemic

2.5

7.9

183

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

7.9

333

2414

G44.8

ICD-10 Finland

Other specified headache syndromes

2.3

7.8

251

D11

ICPC

Diarrhoea

1.4

7.8

384

2857

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

7.8

316

2274

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.6

7.8

199

1305

SPAT1312

SPAT

General health counselling

1.3

7.8

919

7708

H02AB09

ATC

hydrocortisone; systemic

2.0

7.8

377

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

7.8

653

5255

P01BA01

ATC

chloroquine; systemic

4.2

7.7

SBB10

NOMESCO Finland

Dental impressions

1.6

7.7

198

1299

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

7.7

419

3168

ND2CG

NOMESCO Finland

Extensive MRI of hand

6.4

7.7

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

7.7

540

RF310, ,

NOMESCO Finland

4.3

7.7

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

7.4

7.7

H15.0

ICD-10 Finland

Scleritis

4.5

7.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.6

2386

22072

A02BX02

ATC

sucralfate; oral

1.9

7.6

513

B80

ICPC

Iron deficiency anaemia

2.0

7.6

394

H81.0

ICD-10 Finland

Ménière disease

2.2

7.6

300

H16.9

ICD-10 Finland

Keratitis, unspecified

2.2

7.6

274

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

7.6

528

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

6.7

7.6

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

7.6

429

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

25.0

7.6

NHG22

NOMESCO Finland

Fusion of subtalar joint

3.3

7.5

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

7.5

171

1093

3005

Kela drug reimbursment

Tofacitinib

4.2

7.5

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

7.4

264

1854

SPAT1216

SPAT

Assessment of functional ability

1.4

7.4

358

2655

7119L

ICD-9 Finland

Arthropathy associated with infections, Unspecified infective arthritis[ARTHRITIS INFECTIOSA NUD,USEAT NIVELET]

80.3

7.4

Z01.7

ICD-10 Finland

Laboratory examination

1.3

7.4

528

4154

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.0

7.4

109

RF212, ,

NOMESCO Finland

6.0

7.4

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.4

7.3

208

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.9

7.3

434

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

7.3

163

1035

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.3

7.3

246

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

2.8

7.3

126

VALMI, ,

NOMESCO Finland

1.3

7.3

755

6229

7200A, ,

ICD-10 Finland

+∞

7.3

G56.8

ICD-10 Finland

Other mononeuropathies of upper limb

3.6

7.3

R07.0

ICD-10 Finland

Pain in throat

1.5

7.3

237

1636

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

7.3

448

3452

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

7.3

129

774

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.5

7.2

173

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.5

7.2

173

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

3.2

7.2

G04CB01

ATC

finasteride; oral

1.5

7.2

254

1780

R21

ICPC

Throat symptom/complaint

1.3

7.2

677

5519

-44

ICPC

Preventive immunization/medic

1.5

7.2

201

1344

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

7.2

335

2469

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

7.2

302

2187

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

7.2

303

2196

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

7.2

300

2171

K59.0

ICD-10 Finland

Constipation

1.6

7.2

143

884

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

7.2

584

4677

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

7.2

523

4128

WX702

NOMESCO Finland

Supraglottic ventilation device

1.6

7.1

174

1129

S01BC05

ATC

ketorolac; ophthalmic

1.9

7.1

431

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

7.1

214

1453

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.3

7.1

211

4AA24, ,

NOMESCO Finland

20.0

7.1

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

7.1

249

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

7.1

230

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.1

1180

10246

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

7.1

532

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

7.1

175

1139

D05AX02

ATC

calcipotriol; topical

1.8

7.1

106

606

D01AE16

ATC

amorolfine; topical

1.4

7.1

310

2262

R03DC03

ATC

montelukast; oral

1.3

7.1

506

3982

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.8

7.1

526

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

5.6

7.1

WX402

NOMESCO Finland

General anaesthesia

1.3

7.0

722

5950

L11

ICPC

Wrist symptom/complaint

1.4

7.0

275

1967

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

7.0

221

1516

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

4.2

7.0

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

4.2

7.0

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

7.0

110

638

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

7.0

251

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

7.0

455

3533

H40.0

ICD-10 Finland

Glaucoma suspect

1.5

7.0

208

1411

B02.9

ICD-10 Finland

Zoster without complication

1.5

7.0

181

1192

H25.8

ICD-10 Finland

Other senile cataract

1.5

7.0

219

1502

M50.8

ICD-10 Finland

Other cervical disc disorders

3.4

7.0

NDL40

NOMESCO Finland

Repair of tendon of finger with transplant

4.4

7.0

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

6.9

564

4514

ZX112

NOMESCO Finland

Subcutaneous

2.1

6.9

298

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

6.3

6.9

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

5.5

6.9

L60

ICPC

Musculoskeletal, Result test/procedure

7.5

6.9

ZX114

NOMESCO Finland

Intramuscular

2.4

6.9

196

K92.1

ICD-10 Finland

Melaena

1.6

6.9

137

848

A03

ICPC

Fever

1.3

6.8

559

4477

S01KA02

ATC

hypromellose; ophthalmic

2.4

6.8

178

SAA04

NOMESCO Finland

Special examination of mouth

1.6

6.8

153

974

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.5

6.8

160

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

3.4

6.8

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.3

6.8

209

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

6.7

6.8

1222

FHL

Arthroscopy and synovial surgery

2.6

6.8

137

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

6.8

446

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.8

1187

10353

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

6.8

200

1355

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

6.8

208

1421

L04AA32

ATC

apremilast; oral

4.3

6.7

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

6.7

133

821

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

6.7

169

1105

EB1VA, ,

NOMESCO Finland

1.3

6.7

593

4796

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

6.7

267

1916

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.7

6.7

105

609

N06AB04

ATC

citalopram; systemic

1.3

6.7

599

4855

SPAT1254

SPAT

Administration of medicine

1.4

6.7

359

2710

C03AA03

ATC

hydrochlorothiazide; oral

1.5

6.7

197

1335

R01AD09

ATC

mometasone; nasal

1.2

6.7

1520

13585

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

6.6

411

3169

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

4.0

6.6

B01AB04

ATC

dalteparin; parenteral

1.6

6.6

133

825

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

6.6

459

3597

R00.2

ICD-10 Finland

Palpitations

1.4

6.6

239

1686

CHC05

NOMESCO Finland

Iridotomy

2.4

6.6

169

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.6

587

4753

E000006, ,

ATC

1.5

6.6

169

1111

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

6.6

170

1120

RF214, ,

NOMESCO Finland

8.7

6.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

6.5

553

4448

K07.68

ICD-10 Finland

Other disorders of the jaw joint

3.0

6.5

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.3

6.5

207

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

6.5

122

743

WX204

NOMESCO Finland

Axillary plexus blockaced

1.7

6.5

105

614

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

6.5

438

D07AB08

ATC

desonide; topical

1.4

6.5

304

2243

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

6.8

6.5

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

6.5

128

790

A99

ICPC

Disease/condition unspecnature/site

1.4

6.5

296

2175

C08CA02

ATC

felodipine; oral

1.5

6.5

218

1516

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

2.9

6.5

101

N05BA01

ATC

diazepam; systemic, rectal

1.3

6.5

362

2750

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

6.4

121

738

SPAT1204

SPAT

Arthrocentesis

3.1

6.4

NHG20

NOMESCO Finland

Fusion of talocrural joint

3.1

6.4

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

6.4

320

2386

M49

ICD-10 Finland

Spondylopathies in diseases classified elsewhere

70.0

6.4

71107

ICD-8 Finland

Acute nonpyogenic arthritis, Loco multiplici

70.0

6.4

L08

ICPC

Shoulder symptom/complaint

1.2

6.4

719

5981

D19

ICPC

Teeth/gum symptom/complaint

1.2

6.4

1018

8788

WYA30, ,

SPAT

3.0

6.4

SGA01

NOMESCO Finland

Emergency treatment

1.3

6.4

565

4571

S01EA03

ATC

apraclonidine; ophthalmic

2.9

6.4

102

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

6.4

3309

31888

R1250

NOMESCO Finland

Evaluation of functional capability

1.9

6.4

406

M25.4

ICD-10 Finland

Effusion of joint

2.2

6.3

216

WX203

NOMESCO Finland

Infraclavicular plexus blockade

1.9

6.3

392

N05AH02

ATC

clozapine; systemic

0.2

6.3

341

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

6.5

6.3

A60

ICPC

General and Unspecified, Result test/procedure

1.7

6.3

117

711

R74

ICPC

Upper respiratory infection acute

1.2

6.3

1115

9719

ZXD35

NOMESCO Finland

Usual procedure

1.8

6.3

523

K08.80

ICD-10 Finland

Toothache NOS

1.4

6.3

290

2135

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

6.3

320

2394

A28

ICPC

Limited function/disability NOS

1.3

6.3

398

3078

D99

ICPC

Disease digestive system other

2.6

6.3

131

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

6.3

121

743

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.5

6.3

161

1059

S01ED02

ATC

betaxolol; ophthalmic

3.3

6.3

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

6.3

210

1460

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

6.3

760

6376

RJ421, ,

NOMESCO Finland

3.8

6.3

NA6CM

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with 3 Tesla magnet

+∞

6.2

NA6BF

NOMESCO Finland

Sacro-iliac joint MRI examination with median intensity magnet

+∞

6.2

D06

ICPC

Abdominal pain localized other

1.4

6.2

249

1788

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

6.2

181

1222

71319

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis NUD

26.7

6.2

NAK30

NOMESCO Finland

Osteotomy of spine

26.7

6.2

-31

ICPC

Medical examin/health eval partial

1.5

6.2

164

1085

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

6.2

159

1045

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.6

6.2

126

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.9

6.2

360

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

6.2

556

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

6.2

234

1665

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.1

6.2

258

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

6.2

578

4707

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.9

6.2

389

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

6.2

265

1929

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.0

6.1

292

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

6.1

145

936

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

5.7

6.1

SPAT1211

SPAT

Application of soft bandage

1.4

6.1

218

1534

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.1

6.1

259

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

6.1

103

611

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

6.1

188

1286

D01AC02

ATC

miconazole; topical

1.5

6.1

202

1402

7151E

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, LONKKANIVEL]

4.1

6.1

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

6.1

204

1419

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

6.1

355

2714

S01EE03

ATC

bimatoprost; ophthalmic

2.1

6.0

247

R51.81

ICD-10 Finland

Facial pain NOS

1.9

6.0

406

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.2

6.0

234

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

10.0

6.0

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.4

6.0

158

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

3.5

6.0

R03BA01

ATC

beclometasone; inhalant

1.3

6.0

382

2957

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

298

128

25.17

307.65

1.9

2.4

9.12

9.19

mg/l

0.05

236

112

(3002030) Lymphocytes/Leukocytes in Blood

2913

16296

4.35

307.65

13.6

6.7

29.97

28.17

18.11

2847

15540

(3013650) Neutrophils [#/volume] in Blood by Automated count

3207

19239

5.23

307.65

16.0

10.0

3.91

4.09

e9/l

5.92

3030

16750

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

249

29.87

307.65

1.6

1.8

164.73

67.38

au/ml

—

(3022096) Basophils/Leukocytes in Blood

2877

15819

4.35

307.65

14.0

6.8

0.74

0.69

6.65

2798

14916

(3018010) Neutrophils/Leukocytes in Blood

2883

16033

4.29

307.65

13.4

6.6

55.85

57.02

7.29

2828

15406

(3013115) Eosinophils [#/volume] in Blood

3173

17916

5.63

307.65

13.8

6.8

0.18

0.19

e9/l

4.35

3030

15789

(3006315) Basophils [#/volume] in Blood

3138

17359

5.60

307.65

13.6

6.6

0.04

e9/l

2.68

2960

15040

(3001604) Monocytes [#/volume] in Blood

3135

17326

5.59

307.65

13.5

6.6

0.59

0.58

e9/l

3.94

2956

15014

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

777

1167

8.11

307.65

1.6

1.5

0.65

7.14

iu/ml

0.52

180

193

(3006504) Eosinophils/Leukocytes in Blood

2885

15831

4.40

307.65

13.7

6.7

2.67

2.86

5.88

2810

14936

(3019198) Lymphocytes [#/volume] in Blood

3155

17725

5.55

307.65

13.6

6.6

2.03

1.93

e9/l

2.79

3014

15747

(3019069) Monocytes/Leukocytes in Blood

2895

15863

4.44

307.65

13.9

6.8

8.91

8.79

1.78

2812

14983

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

152

51.03

263.93

1.8

2.0

1.67

1.61

mg/l

0.07

127

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3495

24341

6.32

263.23

10.9

4.2

12.19

10.62

mm/h

10.04

3421

22979

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

140

55.86

247.58

1.5

1.8

—

(3008898) HLA-B27 [Presence]

566

1365

4.70

218.51

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

2720

17215

3.03

208.63

5.3

3.6

0.00

estimate

0.80

628

3550

(3009261) Glucose [Presence] in Urine by Test strip

2745

17495

3.04

207.14

5.4

3.6

0.02

0.10

estimate

0.43

608

3357

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3443

25161

4.85

207.12

13.3

8.3

75.35

77.39

u/l

2.72

3369

24080

(3035350) Ketones [Presence] in Urine by Test strip

2731

17425

3.01

204.31

5.3

3.6

6.79

5.52

estimate

0.12

637

3600

(3037522) Nuclear Ab [Titer] in Serum

1201

5078

2.99

196.76

1.5

1.4

439.58

500.23

titre

0.71

286

1026

(3017732) Neutrophils [#/volume] in Blood

1084

4334

3.10

196.10

3.6

3.2

4.01

4.70

e9/l

3.20

973

3854

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

181

140

13.52

190.44

3.2

3.3

7.25

8.76

mg/l

1.51

148

113

(3015736) pH of Urine

2293

13975

2.61

176.38

4.4

3.2

6.21

6.19

0.49

1212

8135

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

162

124

13.60

171.38

2.9

2.7

80.48

108.67

au/ml

0.25

(3023420) DNA double strand Ab [Units/volume] in Serum

528

1464

4.03

167.73

1.5

1.9

6.72

6.55

iu/ml

0.05

116

368

(3002179) Metamyelocytes/Leukocytes in Blood

782

2897

3.14

158.00

5.5

4.5

0.39

0.72

4.46

210

853

(40760892) CBC W Ordered Manual Differential panel - Blood

1548

8148

2.52

157.96

8.0

4.6

—

(3017181) Myelocytes/Leukocytes in Blood

802

3028

3.09

156.69

6.2

4.7

0.63

0.95

3.04

213

894

(3021440) Promyelocytes/Leukocytes in Blood

778

2905

3.11

154.81

6.3

4.7

0.05

0.13

3.41

185

772

(3025159) Blasts/Leukocytes in Blood

777

2946

3.06

150.15

6.7

4.9

0.46

0.21

0.22

183

721

(3021589) Normoblasts [#/volume] in Blood

2276

15021

2.28

129.40

17.9

11.2

0.00

e9/l

1.56

2047

12264

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

345

865

4.29

124.44

1.7

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2236

14830

2.23

123.07

3.0

2.4

76.02

75.48

nmol/l

0.42

2122

13699

(3035933) Granulocytes/Leukocytes in Blood

308

735

4.47

118.33

3.8

3.3

55.04

58.04

4.10

308

735

(3000475) Leukocytes [#/volume] in Synovial fluid

317

813

4.16

110.66

2.1

1.7

7862.42

14240.70

e6/l

2.00

240

569

(3048689) Calprotectin [Mass/mass] in Stool

950

4595

2.42

109.80

4.1

2.6

174.29

128.72

ug/g

3.20

827

3758

(3017143) Hepatitis C virus Ab [Presence] in Serum

937

4534

2.41

107.97

1.5

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

708

3074

2.60

102.44

1.4

1.5

—

(3045424) Erythrocytes [Presence] in Urine

449

1528

3.20

102.20

2.3

2.1

0.00

0.51

estimate

0.51

169

501

(40758558) Short blood count panel - Blood

1625

10062

2.07

99.94

9.2

6.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1537

9365

2.08

98.35

6.1

3.8

0.00

estimate

2.17

601

3299

(3045414) Leukocytes [Presence] in Urine

672

2955

2.55

94.06

2.2

2.1

0.00

0.01

estimate

1.06

192

651

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1074

5923

2.13

87.66

1.6

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1930

13303

1.91

81.81

5.4

3.5

0.92

0.07

estimate

0.46

546

2971

(3014051) Protein [Presence] in Urine by Test strip

1513

9635

1.95

81.38

3.3

2.7

0.00

0.02

0.80

170

(3018095) Leukocytes [#/volume] in Urine

1784

12041

1.91

80.08

4.6

3.9

42.99

83.97

e6/l

3.70

1237

8470

(3006571) Granulocytes/Leukocytes in Synovial fluid

168

355

4.90

74.57

2.0

1.6

53.51

58.83

0.74

104

222

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1322

8323

1.90

71.34

2.9

2.3

2.85

2.73

mg/l

1.46

1177

7250

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3667

32786

4.22

70.53

26.1

14.9

17.49

23.28

mg/l

33.63

3407

26845

(3003329) Lymphocytes/Leukocytes in Synovial fluid

134

274

5.03

61.77

1.9

1.5

36.42

30.89

0.75

167

(3024561) Albumin [Mass/volume] in Serum or Plasma

1950

14290

1.75

60.48

5.6

5.3

36.25

36.21

g/l

0.13

1857

13499

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2091

15667

1.74

59.55

7.2

7.7

1.21

mmol/l

1.78

1843

13662

(3019150) Specific gravity of Urine by Refractometry

1196

7651

1.82

58.94

5.9

3.7

1.02

1.42

kg/l

0.80

888

5041

(3022145) Colonoscopy Study observation

714

3852

2.05

58.82

1.6

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1906

14020

1.72

57.07

6.6

7.0

1.21

mmol/l

3.06

1808

13086

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1625

11632

1.69

52.28

4.4

3.4

—

1.33

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1412

9745

1.71

51.94

4.3

3.0

0.04

0.14

estimate

0.48

520

2831

(3000850) Epithelial cells [#/volume] in Urine

1109

7170

1.77

51.38

3.0

2.7

4.17

5.18

e6/l

2.47

1030

6531

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

965

6016

1.81

50.42

1.3

14.21

9.10

u/ml

1.28

413

2456

(3005719) IgG [Mass/volume] in Serum or Plasma

547

2828

2.09

49.92

2.5

2.9

11.01

10.62

g/l

1.39

515

2613

(3022948) Iron [Moles/volume] in Serum or Plasma

896

5523

1.81

48.31

2.6

12.50

13.84

umol/l

6.61

831

5190

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

311

1321

2.47

45.29

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

995

6513

1.71

42.74

1.3

34.95

28.95

iu/ml

0.42

309

1934

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2067

16228

1.60

42.73

3.7

3.1

114.37

124.86

ug/l

1.66

1967

15370

(3018418) pH of Serum or Plasma

1333

9421

1.64

42.64

4.0

4.4

7.40

0.09

951

6710

(3004789) Transferrin [Mass/volume] in Serum or Plasma

825

5152

1.77

41.77

2.6

2.36

2.34

g/l

0.41

762

4806

(3031040) Bacteria [#/volume] in Urine by Automated count

2495

20549

1.62

41.72

5.3

4.3

271.64

1282.90

e6/l

1.96

266

(3034891) Synovial lining cells/cells in Synovial fluid

143

5.62

41.70

1.6

1.5

4.00

4.41

0.06

(3002582) Erythrocytes [#/volume] in Urine

1442

10474

1.61

40.78

3.9

3.4

45.86

91.61

e6/l

1.75

1181

7962

(46235355) HIV 1 and 2 tests - Meaningful Use set

1077

7305

1.66

39.99

1.8

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

768

4752

1.77

39.93

2.6

2.7

21.53

23.82

4.88

708

4470

(3028026) IgM [Mass/volume] in Serum or Plasma

429

2201

2.07

39.47

1.6

1.9

1.27

1.34

g/l

0.40

410

2059

(3030467) Casts [#/volume] in Urine by Automated count

1271

9019

1.61

39.22

3.6

3.3

0.35

0.37

e6/l

0.14

999

6560

(3010144) Erythrocytes [#/volume] in Synovial fluid

115

299

3.93

39.09

1.9

1.4

43522.12

89177.43

e6/l

0.47

209

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

235

958

2.55

37.23

1.2

1.3

—

(3027945) Reticulocytes/Erythrocytes in Blood

593

3482

1.83

36.42

2.2

2.7

1.82

1.80

0.26

527

3141

(3007164) IgA [Mass/volume] in Serum or Plasma

1049

7208

1.63

36.37

1.5

2.76

2.43

g/l

5.42

714

4716

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2131

17221

1.54

35.99

5.9

6.7

10.21

11.49

umol/l

5.48

2033

16513

(3019309) Folate [Moles/volume] in Red Blood Cells

741

4692

1.72

34.99

1.8

1.7

1104.83

1147.33

nmol/l

0.67

575

3660

(3015171) Extractable nuclear Ab [Units/volume] in Serum

300

1405

2.23

34.74

1.3

1.2

1.33

0.90

u/ml

0.15

106

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3466

31757

2.02

33.76

20.4

14.1

88.45

85.43

ml/min/173m2

16.15

3305

29363

(3032080) INR in Blood by Coagulation assay

1816

14348

1.51

32.88

13.9

13.5

1.20

1.21

inr

0.48

1535

11948

(3030981) Hyaline casts [#/volume] in Urine by Automated count

457

2584

1.87

31.37

2.5

0.33

0.44

e6/l

0.53

434

2458

(3023368) Bacteria identified in Blood by Culture

1188

8642

1.54

31.33

4.7

4.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1227

8998

1.54

31.15

2.7

331.36

342.62

umol/l

3.84

1099

8105

(3023520) Reticulocytes [#/volume] in Blood

457

2650

1.82

28.82

2.3

2.8

72.04

71.23

e9/l

0.18

334

1930

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

404

2283

1.86

27.64

1.9

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1163

8642

1.50

26.86

1.8

1.7

19.98

19.85

nmol/l

0.11

1033

7470

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3682

34937

2.64

26.61

24.1

11.6

27.43

28.12

u/l

1.60

3648

34163

(3020630) Protein [Mass/volume] in Serum or Plasma

434

2536

1.80

26.59

1.9

2.8

67.62

66.84

g/l

1.22

407

2371

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3690

35071

2.70

26.17

28.7

18.7

76.61

77.48

umol/l

0.78

3676

34748

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

816

5659

1.56

25.83

3.1

2.9

0.75

1.02

e6/l

1.67

494

2954

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3104

28062

1.57

25.19

28.0

18.2

13.73

13.50

18.14

3088

27719

(3004588) Protein electrophoresis panel - Serum or Plasma

360

2028

1.86

24.78

1.8

2.5

—

(3024263) Appearance of Synovial fluid

165

4.12

24.60

2.9

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

221

1076

2.12

23.11

1.3

142.94

101.11

titre

0.24

108

(3042936) Bacteria identified in Isolate by Culture

698

4789

1.56

22.86

2.4

2.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

245

1251

2.02

22.54

1.4

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1340

10516

1.42

22.27

3.0

2.7

59.66

67.17

u/l

0.47

1256

9852

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1694

13882

1.40

21.77

2.3

2.0

93.07

96.43

pmol/l

2.47

1014

7631

(40768797) Stomach Pathology biopsy report

669

4602

1.55

21.53

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

124

493

2.57

20.72

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

285

1578

1.87

20.65

2.0

2.1

38.16

39.85

u/l

0.82

262

1430

(3009445) Proteinase 3 Ab [Units/volume] in Serum

266

1458

1.89

19.88

1.5

1.6

6.22

15.17

iu/ml

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

550

3700

1.57

19.38

3.1

4.6

230.62

240.63

u/l

0.94

515

3521

(3004809) Band form neutrophils/Leukocytes in Blood

123

507

2.47

19.08

2.6

3.5

1.11

1.69

1.02

111

465

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

211

1087

2.00

18.93

1.6

1.7

0.23

0.24

g/l

0.39

201

1037

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1057

8137

1.41

18.89

1.3

1.09

1.70

u/ml

1.50

282

2272

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1821

15323

1.36

18.87

2.9

2.8

—

estimate

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

256

1410

1.87

18.84

1.6

1.8

1.58

1.52

g/l

0.47

216

1232

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1102

8582

1.40

18.31

3.1

974.87

1153.58

ng/l

0.98

909

7250

(3026782) Osmolality of Urine

821

6118

1.44

17.37

3.0

2.9

532.68

541.11

mosm/kgh2o

0.53

744

5368

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

212

1130

1.93

17.24

1.6

1.7

1.22

1.20

g/l

0.53

205

1079

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1461

12004

1.35

17.11

3.5

3.4

32.46

34.68

u/l

0.61

1387

11402

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

221

1198

1.90

17.08

1.7

2.4

3.99

3.73

g/l

1.67

212

1120

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1000

7736

1.40

17.06

1.9

1.8

1.02

1.10

mg/l

0.41

758

5903

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

221

1199

1.90

17.04

1.7

2.4

7.42

7.28

g/l

0.53

212

1119

(3015377) Calcium [Moles/volume] in Serum or Plasma

1342

10897

1.36

16.92

3.0

3.5

2.35

mmol/l

0.02

1241

10023

(3000494) Fungus identified in Specimen by Culture

603

4257

1.49

16.83

1.6

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

1198

1.89

16.77

1.7

2.4

4.36

4.22

g/l

1.37

211

1119

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

713

5209

1.45

16.70

2.0

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

181

925

2.00

16.63

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

142

666

2.18

16.38

1.6

0.60

0.80

g/l

1.67

108

522

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1454

12033

1.34

15.88

4.0

3.5

83.34

58.42

ng/l

0.21

969

7782

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1138

1.88

15.64

1.6

2.4

3.04

2.89

g/l

1.32

199

1059

(3013826) Glucose [Moles/volume] in Serum or Plasma

2186

19216

1.32

15.46

5.3

6.49

6.66

mmol/l

4.04

2078

18213

(3019550) Sodium [Moles/volume] in Serum or Plasma

3482

33056

1.63

15.43

20.1

17.0

139.55

139.70

mmol/l

3.81

3448

32473

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1229

9957

1.35

15.36

2.2

2.3

171.71

233.47

u/l

2.27

1174

9492

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

194

1054

1.89

14.91

3.2

2.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

140

681

2.10

14.74

1.8

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

559

3990

1.47

14.62

2.0

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

832

6381

1.39

14.60

1.8

1.7

29501804.76

33412965.22

pmol/l

0.07

722

5471

(3036481) Cortisol [Moles/volume] in Serum or Plasma

484

3358

1.51

14.57

2.2

2.3

358.28

372.38

nmol/l

0.64

455

3144

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

172

905

1.94

14.56

1.7

2.4

0.00

0.02

g/l

1.46

160

827

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

193

1055

1.87

14.56

1.7

2.5

0.75

1.02

g/l

0.50

175

926

(3026008) Bacteria identified in Urine by Culture

1061

8465

1.35

14.51

3.4

2.9

—

(40761536) Microorganisms panel - Urine sediment

396

2636

1.56

14.42

4.9

3.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3484

33159

1.60

14.31

20.3

17.2

3.95

3.97

mmol/l

4.31

3439

32516

(3004616) Nuclear Ab [Presence] in Serum

413

2.38

14.11

1.3

1.2

—

(3019225) pH of Specimen

410

2777

1.53

13.79

4.2

7.35

0.05

326

2051

(3044640) Blood type and Crossmatch panel - Blood

1281

10567

1.32

13.79

2.6

2.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

353

2.47

13.56

1.3

—

titre

—

(3036071) Salmonella sp Ab [Titer] in Serum

119

3.64

13.55

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1008

8053

1.34

13.48

2.7

2.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

179

988

1.85

13.12

1.4

1.3

3.17

8.48

u/ml

1.50

134

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1030

1.83

12.90

1.7

2.5

10.82

10.34

g/l

0.73

175

946

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

170

933

1.86

12.70

1.9

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

174

967

1.84

12.49

2.2

3.8

32.54

69.36

mg/l

1.48

142

827

(3017354) Segmented neutrophils/Leukocytes in Blood

325

2.46

12.43

2.5

3.6

57.62

56.84

0.12

287

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

149

790

1.92

12.38

1.3

1.2

9.07

3.53

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

175

981

1.82

12.22

1.4

1.3

2.79

3.10

u/ml

0.11

(3034860) Kappa light chains.free [Mass/volume] in Serum

173

967

1.83

12.20

2.2

3.8

48.31

57.55

mg/l

0.53

140

827

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

184

1051

1.79

12.08

1.3

1.2

30.41

41.92

u/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

300

2.50

12.02

2.2

4.2

—

(3025941) Bacteria identified in Stool by Culture

300

1963

1.57

11.75

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

426

2.21

11.48

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

158

877

1.84

11.41

1.7

2.4

0.00

g/l

-0.00

142

778

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

174

995

1.78

11.40

1.9

2.2

11.03

11.59

mg/l

0.40

164

935

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

149

814

1.86

11.32

1.8

2.5

0.00

g/l

-0.00

142

777

(3022621) pH of Urine by Test strip

366

2526

1.50

11.22

3.0

2.3

5.98

6.07

1.10

245

1639

(3038026) Centromere Ab [Units/volume] in Serum

241

2.60

11.01

1.2

132.00

62.95

u/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

120

617

1.98

10.94

1.3

1.2

356.92

408.09

titre

0.09

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

535

3983

1.40

10.93

2.7

2.9

7.53

7.84

umol/l

0.10

464

3517

(4062490) Immunoglobulin typing, IgG

392

2.22

10.76

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

280

2.45

10.73

1.3

1.2

—

70.22

—

(40768443) Skin Pathology biopsy report

228

1428

1.63

10.72

1.3

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

153

860

1.81

10.63

2.2

3.6

1.64

3.12

ratio

1.40

485

(3037756) Immunofixation for Serum or Plasma

115

593

1.97

10.42

1.3

1.8

—

(3007461) Platelets [#/volume] in Blood

3704

36110

1.95

10.39

37.7

22.5

266.88

251.45

e9/l

37.61

3678

35514

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

195

1185

1.68

10.31

2.3

2.0

—

(3035941) MCH [Entitic mass]

3704

36123

1.94

10.18

37.4

22.4

30.36

30.33

0.52

3695

35834

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3704

36123

1.94

10.18

37.5

22.4

91.52

90.77

21.47

3695

35835

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3704

36125

1.94

10.14

38.1

23.0

40.57

41.46

3.85

3695

35823

(3000963) Hemoglobin [Mass/volume] in Blood

3705

36138

1.94

10.14

37.8

22.6

135.23

137.90

g/l

26.97

3694

35853

(3026361) Erythrocytes [#/volume] in Blood

3704

36127

1.93

10.11

37.6

22.5

4.48

4.58

e12/l

27.34

3670

35443

(3009871) Measles virus Ab [Titer] in Serum

166

2.85

10.05

1.7

2064.00

2852.17

titre

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

179

1071

1.70

10.04

2.1

1.8

—

(3010813) Leukocytes [#/volume] in Blood

3704

36135

1.93

9.98

37.7

22.5

6.98

6.69

e9/l

11.45

3671

35443

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

354

2488

1.47

9.89

2.5

2.4

28.02

18.95

au/ml

1.26

297

(3024139) IgG subclass 3 [Mass/volume] in Serum

396

2.15

9.71

1.3

0.39

g/l

0.05

280

(36660697) Celiac disease serology panel - Serum

393

2828

1.43

9.69

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

397

2.14

9.65

1.3

3.44

2.98

g/l

1.36

283

(3027135) IgG subclass 1 [Mass/volume] in Serum

397

2.14

9.65

1.3

6.40

6.66

g/l

0.37

283

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

437

3216

1.41

9.50

2.5

2.3

0.22

g/l

0.20

405

3021

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

662

5218

1.33

9.28

3.4

3.1

2.66

2.13

e6/l

0.62

339

2501

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

427

2.06

9.08

1.2

—

(3049717) Cytology report of Urine Cyto stain

183

1135

1.64

8.98

2.8

2.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

748

6027

1.30

8.90

2.7

3.0

2.45

2.44

mmol/l

0.75

671

5421

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3191

30340

1.32

8.84

5.2

5.1

1.75

1.85

mu/l

6.05

3009

28495

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

327

2313

1.45

8.84

1.3

66.31

53.75

au/ml

0.39

154

(3036670) Protein [Mass/volume] in Synovial fluid

3.51

8.78

1.4

1.2

42.68

38.46

g/l

0.62

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2482

22913

1.24

8.74

3.3

3.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

506

3869

1.36

8.68

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

329

2.18

8.61

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

181

2.62

8.58

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

260

1768

1.51

8.57

3.9

3.5

2.06

1.70

mmol/l

0.86

190

1318

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2742

25617

1.25

8.55

4.2

4.3

14.86

14.63

pmol/l

5.37

2569

23892

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

322

2287

1.45

8.52

4.1

4.3

85.32

90.10

ng/l

0.34

290

2036

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

853

7026

1.28

8.51

1.7

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

287

2.25

8.41

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

276

2.27

8.30

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

296

2.22

8.24

1.3

1.2

296.43

139.38

titre

0.69

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

296

2.22

8.24

1.1

—

(3022313) Gas panel - Capillary blood

217

1435

1.54

8.16

4.9

3.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

505

1.90

7.96

1.1

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

175

1108

1.61

7.94

4.6

3.7

25.17

24.82

mmol/l

1.04

163

1030

(3005322) IgE [Units/volume] in Serum or Plasma

338

2461

1.41

7.80

1.4

1.3

205.37

222.28

u/ml

0.08

321

2293

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

284

2.20

7.77

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

284

2.20

7.77

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

167

2.59

7.75

2.4

2.2

2.88

3.01

ug/l

0.07

157

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

185

2.50

7.73

1.6

1.5

6.58

6.02

u/l

0.09

157

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

371

2.04

7.73

1.9

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

378

2.03

7.71

1.9

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

194

1269

1.56

7.67

2.1

2.0

0.91

1.83

ug/l

2.26

175

1151

(3009343) pH of Capillary blood

288

2049

1.44

7.56

4.4

3.6

7.42

7.41

0.57

242

1696

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

329

2.09

7.44

2.8

2.2

19.17

19.38

mg/l

0.01

125

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

245

2.26

7.39

1.5

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

359

2.02

7.28

1.9

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

4.15

7.27

1.6

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.83

7.24

1.3

1.5

461545.42

591119.15

nmol/l

0.08

(3003327) Ova and parasites identified in Stool by Light microscopy

195

1295

1.53

7.22

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

260

1831

1.45

7.22

1.8

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

361

2.01

7.18

1.9

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

362

2.01

7.12

1.9

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

376

1.99

7.11

1.9

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

250

2.22

7.06

1.5

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

264

2.18

6.99

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

542

4314

1.30

6.96

5.9

6.8

1.03

mmol/l

0.21

511

4055

(3011412) CD3 cells [#/volume] in Blood

338

2.03

6.95

1.8

2.6

1186.15

1201.00

e6/l

0.04

303

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

291

2109

1.41

6.91

4.5

3.6

5.30

5.16

kpa

1.82

278

2031

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

146

921

1.61

6.78

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

276

2.12

6.67

1.3

1.7

—

(3025577) Chromium [Mass/volume] in Blood

162

2.48

6.67

2.4

2.2

1.88

2.15

ug/l

0.23

139

(3014765) Yersinia sp identified in Stool by Organism specific culture

146

926

1.60

6.63

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

218

1511

1.47

6.59

2.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

271

2.12

6.57

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

469

3689

1.31

6.57

1.9

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

312

2.04

6.53

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

361

4695

0.74

6.51

1.9

2.0

3.63

ratio

0.01

279

3583

(42529406) Shigella sp [Presence] in Stool by Culture

146

932

1.59

6.47

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

999

8600

1.22

6.45

4.6

4.3

92.41

91.15

0.91

968

8432

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

3.14

6.43

1.6

1.3

41.47

33.67

0.41

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

275

2.09

6.34

1.1

—

0.62

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

680

1.68

6.33

1.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

1317

14759

0.84

6.31

2.8

3.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

142

909

1.58

6.23

1.5

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

112

678

1.67

6.15

1.5

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

348

1.94

6.10

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

323

2437

1.36

6.03

3.4

4.0

1.23

mmol/l

0.55

287

2127

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

198

2.24

5.85

1.0

1.1

1431.55

1433.94

miu/ml

0.01

198

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

224

2.16

5.84

1.6

1.5

4.50

7.61

u/l

2.69

192

(3044927) Protein electrophoresis panel - Urine

286

2.01

5.75

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

137

888

1.56

5.72

2.7

3.1

1.87

index

0.00

483

(21494755) Public health laboratory ask at order entry panel

326

4218

0.75

5.65

1.3

1.4

—

(3042631) Mycobacterium sp identified in Specimen

416

1.82

5.62

2.7

2.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

829

1.58

5.60

2.8

6.4

410.29

758.82

iu/ml

—

111

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

569

4679

1.25

5.57

2.0

2.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

665

5565

1.24

5.56

3.0

3.7

0.81

0.82

mmol/l

0.88

629

5300

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

467

3752

1.28

5.55

7.7

9.0

5.18

5.11

kpa

0.61

446

3628

(3027801) Oxygen [Partial pressure] in Arterial blood

467

3753

1.28

5.54

7.7

8.9

12.65

12.61

kpa

0.06

445

3628

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

523

4279

1.26

5.34

1.9

2.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

416

3310

1.29

5.34

2.8

2.7

126.61

52.33

u/l

0.42

352

2845

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

110

690

1.61

5.30

1.3

1.4

—

(3019977) pH of Arterial blood

464

3748

1.27

5.28

7.7

9.0

7.42

7.41

0.14

242

2076

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

137

914

1.52

5.07

1.6

1.7

—

(3003396) Base excess in Arterial blood by calculation

459

3725

1.26

5.02

7.7

8.9

0.90

0.89

mmol/l

0.02

382

3063

(4024509) Urine culture

188

1341

1.42

4.96

1.7

1.9

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

269

3509

0.75

4.94

1.6

1.7

3.56

3.52

mmol/l

0.18

185

2389

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

294

0.27

4.92

6.8

21.2

1480.63

1420.89

nmol/l

—

287

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

167

1170

1.45

4.86

1.8

2.4

380.36

449.83

ug/l

0.17

154

1110

(3033099) Centromere Ab [Titer] in Serum

3.00

4.82

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

811

1.53

4.82

1.3

1.5

—

(3016502) Oxygen saturation in Arterial blood

416

3354

1.27

4.81

8.0

9.4

95.58

95.85

0.34

399

3252

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

132

885

1.51

4.79

1.5

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

253

1.95

4.63

1.5

2.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

121

806

1.52

4.55

1.3

1.2

38.47

45.76

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

118

2.38

4.39

1.2

1.1

—

5.83

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

542

1.62

4.38

1.3

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

590

4996

1.21

4.35

2.2

29.86

29.62

0.47

573

4865

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

580

1.58

4.19

1.1

1.64

0.90

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

715

6200

1.19

4.07

3.9

3.7

371.33

617.94

ng/l

0.53

504

4543

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

152

1085

1.42

4.05

2.5

2.7

3.90

3.60

g/l

1.52

145

1034

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

143

2.18

3.98

4.1

3.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

176

1293

1.38

3.97

1.2

—

(3044889) 12 lead EKG panel

2430

23079

1.15

3.93

3.9

3.8

0.67

9156.73

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

175

1288

1.38

3.91

1.3

187.44

215.84

miu/ml

0.47

604

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

251

1951

1.31

3.90

9.6

11.4

24.53

24.30

mmol/l

0.54

243

1924

(3016650) Hepatitis A virus Ab [Presence] in Serum

101

671

1.52

3.89

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

151

2.13

3.89

1.8

2.1

25.63

30.06

1.05

151

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

440

3663

1.23

3.84

4.7

32.44

31.25

1.61

344

2555

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

545

1.57

3.84

1.1

1.53

1.48

g/l

0.66

501

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

293

1.79

3.82

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

293

1.79

3.82

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

293

1.79

3.82

1.8

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.95

3.79

2.2

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

236

1.87

3.78

1.9

2.8

485.66

565.12

e6/l

0.40

195

(3020717) Zinc [Moles/volume] in Serum or Plasma

215

1.92

3.76

1.6

1.5

21.45

24.44

umol/l

0.27

200

(3037121) Protein [Mass/volume] in Urine

153

1110

1.39

3.74

3.6

403.84

400.43

mg/l

0.01

515

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

238

1.86

3.69

2.3

3.0

248.13

226.18

e6/l

0.28

208

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

196

1.95

3.67

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

225

1.88

3.63

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

237

1850

1.30

3.59

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

101

684

1.49

3.58

1.6

—

(3000012) Reticulocyte production index

437

1.61

3.56

2.4

2.1

0.95

0.92

0.21

294

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

172

1.99

3.48

2.1

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

222

1.86

3.45

1.9

1.25

1.65

u/field

0.29

121

(3001729) Color of Synovial fluid

4.08

3.39

2.4

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

330

2705

1.24

3.35

2.7

2.6

70.45

70.64

ml/min/173m2

0.03

137

1096

(3020779) Urea [Moles/volume] in Serum or Plasma

364

3016

1.23

3.35

7.0

8.4

9.34

9.29

mmol/l

0.05

348

2909

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

277

2235

1.26

3.24

2.8

2.9

145.72

172.90

ng/l

0.68

252

2017

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

677

1.46

3.19

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

219

1721

1.29

3.18

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

172

1.93

3.13

2.1

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

172

1.93

3.13

2.1

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

172

1.93

3.13

2.1

2.0

—

(3028433) Virus identified in Specimen by Culture

2.25

3.12

1.5

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

173

1.92

3.09

2.0

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

1236

11365

1.13

3.07

3.4

3.6

8.08

8.16

mmol/l

0.26

1069

9819

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1267

11689

1.13

2.95

5.0

4.8

3.48

2.29

ug/l

0.88

1146

10717

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

169

1.90

2.94

2.0

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

633

1.45

2.89

1.5

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

610

1.45

2.85

1.8

—

(3000330) Specific gravity of Urine by Test strip

186

1454

1.29

2.85

3.0

3.1

1.02

ratio

1.09

173

1313

(3034274) Bile acid [Moles/volume] in Serum --fasting

409

1.55

2.79

1.7

2.0

6.42

6.70

umol/l

0.08

292

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

207

1648

1.27

2.75

1.6

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

224

1802

1.26

2.74

1.8

0.28

0.33

mg/l

0.65

105

909

(3002173) Hemoglobin [Mass/volume] in Arterial blood

373

3164

1.20

2.73

8.8

9.9

120.35

123.51

g/l

2.41

366

3096

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

111

2.08

2.72

2.2

3.7

2.27

2.15

ratio

0.12

102

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

133

1.96

2.64

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

274

1.65

2.61

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.26

2.60

1.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

156

1.87

2.56

1.6

1.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.73

2.54

1.8

1.54

1.37

umol/l

0.28

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

147

1137

1.30

2.48

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

446

1.49

2.47

1.3

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

271

1.63

2.46

1.2

1.1

—

1.53

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

550

4860

1.15

2.46

1.6

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

130

994

1.32

2.39

1.4

265.98

283.42

ug/g

0.40

579

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

228

1.67

2.36

1.4

1.2

1.11

1.06

ratio

1.39

186

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

386

1.51

2.35

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

113

849

1.34

2.35

1.5

5786.20

1180.96

e6/l

0.43

661

(3014111) Lactate [Moles/volume] in Serum or Plasma

351

3011

1.18

2.30

8.2

8.8

1.35

1.33

mmol/l

0.14

343

2954

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

155

1.81

2.29

1.7

1.05

4.34

u/field

1.73

117

(3010937) Rubella virus Ab [Presence] in Serum

3.48

2.27

1.1

1.0

—

(40768441) Liver Pathology biopsy report

262

1.61

2.26

1.2

1.6

—

(1616796) Gas panel - Central venous blood

717

1.36

2.25

3.4

3.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

375

1.50

2.22

2.4

2.5

1.56

1.48

g/24h

0.08

231

(3023410) Appearance of Cerebral spinal fluid

375

1.50

2.22

1.5

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3209

31413

1.14

2.21

4.8

5.82

5.89

mmol/l

2.85

3002

29378

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.56

2.21

1.0

183.20

273.22

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

248

1.62

2.21

3.0

2.5

40.24

30.12

mg/l

0.58

174

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

128

1.88

2.21

2.5

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

128

1.88

2.21

2.5

2.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

114

1.94

2.20

1.6

1.8

40.47

40.38

g/l

0.02

114

(3023419) Bacteria identified in Sputum by Culture

434

1.46

2.18

2.6

2.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

644

1.38

2.18

3.9

3.8

411.68

723.15

u/ml

0.30

598

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

143

1.82

2.18

1.1

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

134

1044

1.29

2.18

3.8

4.2

1.37

1.38

mmol/l

0.06

127

1031

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

403

3513

1.16

2.18

7.1

6.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

370

3204

1.17

2.18

4.2

3.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

129

1.87

2.16

2.5

2.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

295

2510

1.19

2.14

1.5

1.4

—

(4034850) Laboratory test

131

1021

1.29

2.13

14.3

9.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

388

1.48

2.11

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

380

1.48

2.10

1.5

1.4

277.54

280.72

mosm/kgh2o

0.45

289

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

254

2138

1.20

2.08

2.6

3.6

4.59

4.54

pmol/l

0.16

229

1939

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

5.00

2.07

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

109

833

1.32

2.06

1.4

1.5

68.40

20.83

e6/l

0.51

612

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

505

4497

1.14

2.04

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

175

0.40

2.02

2.6

2.3

111.57

150.55

nmol/l

—

152

(21494890) Protein electrophoresis panel - 24 hour Urine

303

1.52

2.00

1.9

2.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

167

2046

0.81

1.98

1.5

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.29

1.97

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.29

1.97

2.4

2.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

588

1.37

1.96

1.9

2.0

4.59

5.16

mmol/24h

0.81

536

(3012516) Albumin [Mass/volume] in Urine

1105

10312

1.10

1.96

3.5

3.6

68.65

49.24

mg/l

1.76

705

6781

(3017704) Immunofixation for Urine

164

1.71

1.94

1.3

1.7

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.55

1.94

1.4

1.2

—

mmol/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

258

1.56

1.92

1.3

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

124

975

1.28

1.92

1.2

1.1

3.63

3.96

0.14

157

(3008152) Bicarbonate [Moles/volume] in Arterial blood

234

1972

1.20

1.92

6.7

7.4

25.02

24.43

mmol/l

1.76

221

1891

(3037692) Legionella sp identified in Specimen by Organism specific culture

113

1.86

1.91

1.0

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

166

1.69

1.87

1.4

2.3

67.57

120.42

ng/l

4.93

166

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

205

1.62

1.85

1.3

1.6

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.53

1.83

1.0

1.1

—

33.28

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.06

1.80

1.1

1.4

1.21

1.18

mmol/l

0.94

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.76

1.79

1.5

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

109

1.84

1.77

2.0

1.6

8.72

8.51

ug/l

0.09

109

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.03

1.74

1.5

1.3

2.13

62.57

ug/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

162

1.67

1.74

1.1

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

162

1.67

1.74

1.1

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

233

1.55

1.73

1.1

1.46

1.07

u/l

0.58

107

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

178

1.63

1.72

1.4

1.3

—

68.13

—

(3044009) aPTT.lupus sensitive (LA screen)

2.67

1.72

1.3

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.92

1.72

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.92

1.72

1.4

1.6

197.86

372.33

umol/24h

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

103

1.85

1.71

1.2

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

103

808

1.28

1.66

1.3

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1112

10453

1.09

1.65

4.1

4.3

12.97

8.66

mg/mmol

1.56

707

6759

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

103

810

1.28

1.63

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

103

810

1.28

1.63

1.2

268.10

262.08

u/ml

0.08

518

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

190

1.58

1.59

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

198

1.57

1.59

1.3

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

638

0.70

1.59

1.1

15.36

987.34

iu/ml

—

143

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.33

1.58

1.9

1.8

—

(3012501) Base excess in Blood by calculation

664

1.30

1.58

4.1

4.5

3.10

2.35

mmol/l

1.16

448

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

439

1.37

1.57

1.3

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

107

853

1.26

1.54

1.3

3.45

3.77

mmol/l

4.29

102

801

(44790048) Parainfluenza type 2 nucleic acid detection

450

1.36

1.53

1.3

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

450

1.36

1.53

1.3

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

450

1.36

1.53

1.3

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

450

1.36

1.53

1.3

1.5

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.34

1.52

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

161

1.62

1.52

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

574

1.31

1.48

1.3

1.4

22.28

26.27

u/l

0.60

475

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

342

1.41

1.48

2.4

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

288

2529

1.15

1.48

2.8

2.3

5.13

8.24

ug/l

2.40

247

2293

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

109

1.75

1.46

1.7

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

752

1.27

1.46

2.2

134.37

132.16

g/l

0.41

596

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.23

1.46

1.1

0.03

0.02

u/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

377

1.38

1.46

2.3

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2519

24532

1.08

1.46

3.7

3.4

51.51

47.09

u/l

1.41

2403

23422

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

310

1.42

1.45

1.1

297.12

282.92

mg/l

0.08

264

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

133

1.66

1.42

1.3

1.2

0.31

0.29

g/l

0.64

107

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

118

1.70

1.41

1.3

1.5

15.33

15.36

pmol/l

0.01

103

(44806071) Cardiolipin IgM antibody measurement

2.18

1.39

1.1

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

166

1.57

1.37

1.2

1.3

159.00

179.59

mmol/24h

0.54

166

(3020911) Cortisol [Moles/time] in 24 hour Urine

127

1.66

1.36

1.1

1.6

95.87

360.32

nmol/24h

0.63

127

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.94

1.36

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

264

2322

1.15

1.35

1.2

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

761

7099

1.09

1.34

3.0

0.68

0.72

ug/l

0.77

509

4192

(3047007) Chlamydophila sp Ab [Presence] in Serum

566

1.30

1.34

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

218

1892

1.16

1.34

9.1

11.8

15.89

16.25

1.15

211

1825

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

341

1.38

1.33

1.6

1.5

—

(37208534) Antinuclear antibody arbitrary concentration in serum

105

1.72

1.33

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

426

3869

1.11

1.30

2.3

2.4

14.27

13.85

nmol/l

0.54

385

3570

(3039443) Prostate specific Ag panel - Serum or Plasma

817

0.77

1.30

1.5

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

596

1.28

1.29

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

596

1.28

1.29

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

137

1.61

1.29

1.7

4.6

68.38

61.66

mg/l

0.22

(3009677) Dengue virus Ab [Presence] in Serum

2.78

1.28

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

293

1.40

1.28

1.3

1.2

0.20

1.12

u/ml

2.15

154

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.05

1.26

1.0

—

(3006270) Folate [Moles/volume] in Blood

227

1.46

1.26

1.2

1.1

348.14

375.27

nmol/l

0.34

207

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

153

1299

1.19

1.25

1.9

211.77

214.16

pmol/l

0.11

146

1234

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

157

1336

1.18

1.25

2.3

2.4

3779.46

5356.79

u/l

0.33

525

(4212803) Bone marrow aspirate examination

2.40

1.24

1.0

1.1

—

(3000991) Gas panel - Venous blood

320

2869

1.13

1.24

10.1

10.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

163

1.54

1.22

1.0

1.1

131.54

192.90

iu/ml

1.33

163

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

100

817

1.23

1.22

1.3

1.4

—

23.98

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.16

1.21

1.0

1.1

52.00

85.62

titre

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

322

1.37

1.21

1.2

35.31

41.87

mg/l

0.72

260

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.80

1.21

1.2

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

366

1.34

1.19

1.2

—

29.29

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.83

1.19

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

984

9321

1.08

1.18

4.1

4.0

21.65

21.64

0.01

487

4053

(3020393) Adenovirus Ag [Presence] in Stool

2.31

1.18

1.0

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

167

0.54

1.18

3.3

2.5

33.52

50.03

umol/l

—

149

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

1.50

1.18

1.0

1.1

—

(3036489) Thrombin time

160

1373

1.17

2.2

2.1

20.54

20.79

0.22

139

1210

(3044290) Cell count panel - Cerebral spinal fluid

778

1.23

1.14

1.3

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

300

1.37

1.14

1.4

48111.79

91886.26

e6/l

0.73

171

(40765096) Chromosome analysis panel by Banding

111

0.45

1.12

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.75

1.12

1.1

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

493

1.28

1.12

1.4

0.11

0.29

nmol/l

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3154

31091

1.08

1.12

5.9

37.67

38.83

mmol/mol

12.36

3009

29557

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

1.43

1.12

1.3

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

720

0.77

1.12

1.4

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

310

1.36

1.11

4.1

4.0

—

(3003694) ABO and Rh group [Type] in Blood

1044

9934

1.07

1.10

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

209

1.44

1.10

1.6

—

1178935.93

iu/ml

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

294

1.36

1.09

2.9

2.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.38

1.09

1.4

1.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

160

1.50

1.09

2.1

1.7

2.12

1.95

umol/l

0.42

144

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

121

1427

0.84

1.08

2.0

1.8

7.69

4.57

mg/l

0.92

1051

(3006653) Thiamine [Moles/volume] in Blood

210

1.43

1.08

1.3

1.4

148.60

133.29

nmol/l

1.08

210

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

149

1726

0.86

1.07

1.1

1.48

1.50

g/l

0.46

149

1726

(3002256) Pathology report gross observation

472

4360

1.09

1.06

1.3

—

(3019174) dRVVT (LA screen)

2.12

1.05

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

121

1.57

1.05

2.6

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

121

1.57

1.05

2.6

1.5

—

(3006462) Nitrate [Presence] in Urine

121

1.57

1.05

4.5

3.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

281

2530

1.12

1.05

2.1

2.2

—

(3004451) EKG impression Narrative

187

1.45

1.03

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

625

1.24

1.03

1.3

1.2

2.26

4.00

u/ml

0.81

218

(3038177) Helicobacter pylori Ab [Presence] in Serum

609

0.77

1.01

1.1

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

169

1476

1.15

1.01

2.4

2.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.89

1.01

23.4

9.8

4.20

5.91

mmol/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

646

1.23

1.00

1.1

13.05

16.33

au/ml

0.17

193

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

189

1.43

0.99

1.3

1.7

2.43

7.16

nmol/l

0.96

155

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.18

0.98

1.0

6.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

162

1415

1.15

0.98

5.3

5.6

1.54

1.67

0.86

155

1338

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.96

0.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.1

—

1.10

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.96

0.0

1.2

—

21.10

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

302

1.33

0.95

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

133

1.51

0.94

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

116

991

1.18

0.94

3.6

3.3

0.33

iu/ml

0.01

521

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

110

936

1.18

0.93

1.1

2.52

6.16

eliau/ml

—

129

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

274

2483

1.11

0.93

1.2

98.10

143.61

u/ml

1.18

940

(3023199) Leukocytes [#/volume] in Pleural fluid

347

1.30

0.93

1.6

1.4

1774.47

4763.98

e6/l

0.61

244

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

142

1629

0.87

0.93

1.0

1.1

0.61

0.65

ratio

0.30

181

(3034426) Prothrombin time (PT)

134

1.50

0.91

1.1

1.2

28.35

29.43

0.43

134

(1617658) Protocol used for examination of sentinel lymph nodes

220

0.64

0.91

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.14

0.91

1.5

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.63

0.90

1.1

0.28

1.65

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

402

1.27

0.90

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

746

1.20

0.90

1.3

1.5

143.45

154.63

au/ml

0.28

215

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

232

2090

1.12

0.89

1.9

2.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

263

1.33

0.87

1.2

1.1

16.59

8.45

iu/ml

—

(4211845) Urine protein measurement

136

1.47

0.86

4.3

3.0

—

(40768806) Pleura Pathology biopsy report

290

1.31

0.86

1.4

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.82

0.85

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1485

14381

1.05

0.85

1.9

1.40

1.42

mmol/l

0.36

1279

12375

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

221

1.36

0.85

1.0

936.14

764.52

ng/l

0.72

155

(3027944) Amphetamines [Presence] in Urine

206

1850

1.12

0.84

2.1

2.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

104

1.54

0.84

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

104

1.54

0.84

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

104

1.54

0.84

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

104

1.54

0.84

1.1

—

(3045716) Anion gap in Serum or Plasma by calculation

353

1.28

0.84

3.2

3.6

9.59

10.68

mmol/l

1.39

348

(3011897) Casein IgE Ab [Units/volume] in Serum

1.69

0.82

1.2

1.1

0.01

0.14

u/ml

1.25

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

223

1.35

0.81

1.0

293.18

291.74

ng/l

0.01

159

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

1.48

0.80

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

224

1.34

0.79

1.0

39.81

39.15

ng/l

0.03

154

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

419

1.24

0.79

1.5

1.3

0.17

0.22

nmol/l

0.60

329

(3000764) Benzodiazepines [Presence] in Urine

207

1868

1.11

0.79

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

403

3754

1.08

0.79

1.7

1.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

328

3029

1.09

0.79

3.5

4.5

119.50

18.94

ug/l

0.89

255

2442

(3042517) Benzodiazepines panel - Urine

1.67

0.78

1.4

2.8

—

(3027008) Opiates [Presence] in Urine

208

1879

1.11

0.78

2.2

2.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.78

0.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.78

0.0

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

145

1282

1.14

0.78

3.5

3.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.77

0.0

1.4

—

42.86

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.77

0.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

125

0.56

0.77

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

193

1740

1.12

0.76

2.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.70

0.75

1.3

1.1

0.81

0.75

umol/24h

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

586

1.20

0.75

1.1

118.25

114.97

0.52

543

(3028300) Cannabinoids [Presence] in Urine

208

1886

1.11

0.74

2.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

245

1.31

0.73

1.2

1.3

0.53

0.58

ratio

0.44

134

(3003181) Sodium [Moles/volume] in Urine

552

1.20

0.72

1.6

1.4

63.09

63.10

mmol/l

0.00

447

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

237

1.31

0.72

2.2

2.9

45.56

41.03

0.82

121

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.67

0.72

1.5

1.8

23.19

31.39

pmol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

617

1.19

0.72

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

109

952

1.15

0.72

1.8

2.2

3.27

3.90

iu/l

0.50

410

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.62

0.71

1.0

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

194

0.67

0.70

56.1

41.0

6.69

7.48

ug/l

0.76

177

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.55

0.69

1.2

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.51

0.69

1.2

1.5

—

(44813793) Dust mix specific IgE antibody measurement

239

1.30

0.69

1.2

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.85

0.68

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.67

0.68

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

501

1.20

0.68

3.4

3.0

27.43

142.96

u/ml

0.73

490

(3000034) Microalbumin [Mass/volume] in Urine

266

1.28

0.68

3.9

3.1

175.02

69.19

mg/l

0.35

196

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.63

0.66

2.6

2.5

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

549

0.82

0.65

4.0

2.5

13.26

13.12

0.73

543

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.59

0.65

1.6

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

172

1.34

0.63

2.8

2.3

129.33

164.08

umol/l

0.21

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

378

1.22

0.62

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

129

1154

1.12

0.62

1.5

—

(3044007) Cell count panel - Peritoneal fluid

104

0.58

0.61

2.3

2.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

173

1.33

0.61

1.9

1.6

32.09

28.57

umol/l

1.04

160

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.67

0.61

1.2

2.7

0.20

0.73

u/field

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

407

1.21

0.60

1.3

—

nmol/l

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.60

0.0

1.3

—

21.95

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

660

0.85

0.59

1.6

1.5

0.26

0.36

nmol/l

1.57

509

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.51

0.58

5.0

7.7

9.86

10.63

—

(21494434) Karyotype in Bone marrow

282

1.24

0.58

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

283

1.24

0.56

1.4

1.5

11.40

12.13

umol/l

0.41

264

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

764

0.86

0.56

2.2

2.3

0.80

0.89

nmol/l

0.51

657

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

615

1.16

0.56

1.2

3.03

4.46

u/ml

0.84

286

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.58

0.56

1.0

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.51

0.56

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.62

0.55

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.62

0.55

3.7

5.4

6.88

8.18

mmol/l

—

(1002224) Polysomnography panel

233

2164

1.08

0.54

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

797

1.13

0.53

3.4

3.0

—

(3014891) Appearance of Pleural fluid

1.54

0.53

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.45

0.53

1.3

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.52

0.52

1.1

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.62

0.52

1.7

2.1

13.15

16.27

umol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

100

0.60

0.51

1.8

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

287

1.22

0.51

1.7

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

214

0.75

0.51

2.2

1.6

7.72

7.78

mmol/l

0.06

206

(3014271) Vancomycin [Susceptibility]

109

1.38

0.50

4.9

2.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

288

1.22

0.50

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.49

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.52

0.48

1.1

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.52

0.48

1.6

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

253

1.23

0.48

1.4

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

143

1310

1.10

0.48

1.6

1.7

19.51

14.13

u/ml

0.22

354

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

208

1.25

0.47

2.3

2.8

620.65

919.83

u/ml

0.64

208

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

137

1.32

0.47

1.1

4.21

10.87

u/ml

2.42

(3012544) pH of Venous blood

345

3276

1.06

0.45

4.4

4.1

7.38

0.03

196

1842

(3020491) Glucose [Moles/volume] in Blood

246

1.22

0.45

1.6

1.8

7.20

6.79

mmol/l

0.40

167

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

198

0.76

0.45

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

219

0.78

0.43

2.4

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

138

1498

0.92

0.43

1.6

1029.41

1017.68

mu/l

0.04

121

1223

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.61

0.43

1.0

1.3

—

(3024471) HLA-A [Type]

131

0.69

0.43

1.0

—

(3024932) HLA-DR beta [Type]

131

0.69

0.43

1.4

1.1

—

(4281824) Cell count and differential, peritoneal fluid

306

0.82

0.42

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.2

—

2.53

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.41

0.0

1.2

—

3956.40

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.3

—

316.37

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

6.3

—

102.06

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

5.7

—

493.35

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.40

0.0

1.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.1

—

1.39

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

114

1.32

0.40

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

204

1.23

0.40

1.1

—

(3017569) Oxygen content in Arterial blood

183

0.76

0.40

3.7

2.3

17.04

16.63

0.20

183

(3045788) Cell count panel - Pleural fluid

287

1.19

0.40

1.5

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.43

0.39

1.6

1.2

2.23

1.77

umol/24h

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

242

1.20

0.38

1.3

1.5

77.45

80.32

umol/l

0.31

242

(3042733) HLA Ab [Presence] in Serum

148

0.74

0.38

5.2

4.9

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.36

0.38

1.0

1.5

—

144.75

—

(3020650) Glucose [Presence] in Urine

116

1.29

0.37

1.8

1.6

0.00

0.05

estimate

0.80

116

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

164

1534

1.07

0.37

3.0

3.1

52.61

58.91

u/ml

0.17

157

1479

(4015189) Microbial culture of sputum

1.29

0.36

3.3

2.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

140

1303

1.08

0.36

5.7

5.9

0.89

0.88

0.07

132

1229

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.27

0.36

6.0

7.3

5.56

5.43

kpa

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

157

1468

1.07

0.36

1.6

1.7

265.18

284.43

mu/l

0.29

144

1346

(3033705) Calcium.ionized [Moles/volume] in Venous blood

299

0.84

0.35

2.9

2.5

1.21

1.19

mmol/l

1.46

292

(40768446) Kidney Pathology biopsy report

153

1.24

0.35

1.6

1.7

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

199

1.21

0.35

1.6

1.2

11.25

8.76

mm/h

0.40

199

(4268621) Lupus anticoagulant assay

442

1.13

0.35

2.2

2.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

426

0.87

0.34

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

394

0.86

0.34

1.3

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

699

0.90

0.33

1.7

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.33

0.33

1.3

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

144

0.76

0.33

6.0

6.2

8.45

8.03

0.11

144

(40761995) Spermatozoa Progressive [#/volume] in Semen

144

0.76

0.33

3.0

3.1

43.82

46.51

0.15

144

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.30

0.33

1.5

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

322

1.15

0.32

1.1

—

titre

—

(3012898) Urea [Moles/volume] in Urine

1.28

0.32

1.2

1.5

249.17

164.10

mmol/l

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.35

0.32

1.2

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

123

1146

1.08

0.32

3.6

3.9

5745.35

1503.38

u/ml

0.49

107

1011

(3021447) Carbon dioxide [Partial pressure] in Venous blood

337

3237

1.05

0.32

4.4

4.1

6.02

5.85

kpa

2.19

331

3150

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

119

1.26

0.31

1.1

2.1

200.73

162.89

0.52

113

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

220

1.18

0.31

1.8

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

110

1.27

0.31

1.0

1.3

90.56

89.25

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

248

1.17

0.31

1.8

3.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

113

1051

1.08

0.31

1.6

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.35

0.31

1.0

2.0

—

(3025130) Human papilloma virus identified in Specimen

523

1.11

0.30

2.1

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

137

1285

1.07

0.30

1.4

8.56

8.88

u/l

0.12

112

1036

(4195642) Thrombophilia screening test

581

1.10

0.30

1.1

1.2

—

(44806420) Estimation of glomerular filtration rate

401

1.12

0.29

2.9

2.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

775

1.09

0.29

2.5

3.1

33.05

36.14

umol/l

0.70

717

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

241

1.16

0.29

1.3

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

112

1.25

0.28

1.0

1.2

102.50

88.51

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

344

0.87

0.28

1.3

1.5

1.21

1.30

promille

0.12

270

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.29

0.28

1.1

1.6

—

0.84

—

(3035880) pH of Pleural fluid

149

1.21

0.27

1.7

1.4

7.47

7.40

0.37

105

(3050129) First trimester maternal screen panel - Serum or Plasma

107

1000

1.07

0.27

1.3

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

252

1.15

0.27

1.0

1.2

—

(3002032) Base excess in Venous blood by calculation

326

3152

1.04

0.25

4.4

4.1

1.66

1.80

mmol/l

0.25

292

2759

(4198724) Urine methamphetamine measurement

207

1.16

0.25

1.5

3.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

464

1.10

0.24

1.2

1.6

320.98

330.13

mu/l

0.09

376

(4035726) Immunohistochemistry procedure

287

2769

1.04

0.24

1.3

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

308

0.88

0.24

2.7

2.5

105.93

105.51

mmol/l

0.19

301

(3041354) Potassium [Moles/volume] in Venous blood

308

0.88

0.24

2.7

2.5

4.07

4.04

mmol/l

0.19

301

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

136

0.81

0.23

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.28

0.23

3.6

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

125

1.20

0.22

2.1

2.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

876

0.93

0.22

1.5

59.37

60.04

ug/l

0.05

719

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.74

0.22

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

343

1.11

0.22

2.9

5.4

6.98

7.37

mmol/l

0.32

293

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

527

5151

1.03

0.22

1.8

1.9

1.56

1.47

1.55

473

4580

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.19

0.21

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

8.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

678

0.93

0.21

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.16

0.21

1.8

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

0.76

0.21

2.9

3.7

5.10

4.93

kpa

—

105

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

0.76

0.21

2.9

3.7

11.34

10.31

kpa

—

105

(3027456) Digoxin [Moles/volume] in Serum or Plasma

450

1.09

0.21

3.6

3.4

0.76

0.82

nmol/l

0.53

370

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

2.69

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.20

0.0

1.8

—

(3045142) Bone marrow Pathology biopsy report

384

1.09

0.19

1.3

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

541

1.07

0.18

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.21

0.18

1.4

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.13

0.17

1.3

1.9

1.51

1.65

ug/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

110

1.18

0.17

1.7

1.5

0.57

0.47

e9/l

1.02

110

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.18

0.16

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.18

0.16

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.18

0.16

1.0

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

142

1366

1.04

0.16

3.7

3.6

25.93

25.29

mmol/l

1.38

137

1315

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

877

1.05

0.15

1.8

—

(3005033) Fetal Nuchal fold Thickness US

668

0.94

0.15

1.4

1.5

1.27

0.02

467

(3008536) Aspergillus sp Ab [Presence] in Serum

1.10

0.15

4.1

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

215

2089

1.03

0.15

1.4

24.99

26.18

iu/l

0.21

185

1788

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

472

0.93

0.15

1.3

1.4

208.74

320.42

pmol/l

3.54

400

(40768793) Breast Pathology biopsy report

654

1.06

0.14

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

150

1.13

0.14

1.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

112

1.16

0.14

1.0

1.2

120.54

103.49

1.07

107

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2864

28736

0.99

0.13

30.2

18.6

331.45

333.39

g/l

26.18

2857

28589

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

365

1.07

0.12

1.2

1.4

169.37

196.41

pmol/l

0.46

365

(4146454) Self-monitoring of blood glucose

323

0.93

0.11

3.0

2.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

532

1.05

0.11

1.1

3.77

2.59

eliau/ml

0.26

267

(3044242) Glucose [Moles/volume] in Arterial blood

191

1.10

0.11

3.0

2.1

7.10

8.20

mmol/l

1.50

191

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

302

0.93

0.11

1.1

14.82

17.88

u/ml

—

134

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3353

33464

1.02

0.11

5.5

2.72

2.77

mmol/l

2.78

3190

31713

(3024354) Oxygen [Partial pressure] in Venous blood

275

2699

1.02

0.11

4.0

3.4

4.59

4.65

kpa

0.20

268

2624

(3051387) C reactive protein [Mass/volume] in Capillary blood

622

1.05

0.11

3.2

3.4

22.61

25.40

mg/l

0.29

422

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

136

0.88

0.11

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

662

1.04

0.10

1.0

1.1

4.32

3.03

u/ml

0.20

320

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

741

1.04

0.10

2.1

2.4

99.86

119.25

ug/min

0.21

464

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.09

0.09

1.8

2.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.06

0.09

1.2

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.09

0.08

1.3

1.0

5.22

6.51

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

104

1012

1.03

0.08

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.81

0.08

1.4

2.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.06

0.08

1.6

3.4

4.00

57.04

ug/l

—

(3047181) Lactate [Moles/volume] in Blood

100

974

1.03

0.08

5.8

6.5

1.26

1.33

mmol/l

0.39

849

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.84

0.07

1.0

0.81

4.91

u/ml

—

(3047189) Immunofixation for 24 hour Urine

147

1.09

0.07

2.1

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3318

33136

1.01

0.07

5.0

4.9

4.63

4.67

mmol/l

1.75

3165

31525

(3002523) Influenza virus A Ag [Presence] in Specimen

812

0.97

0.07

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.02

0.07

1.2

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.88

0.06

1.3

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

609

0.97

0.06

1.5

1.2

30.16

39.43

u/l

0.35

526

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

138

1.09

0.06

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

811

0.97

0.06

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.11

0.06

1.0

1.1

—

(4133840) Spirometry

104

0.87

0.06

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

651

1.03

0.06

1.5

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

760

0.97

0.06

1.0

1.1

0.51

1.13

u/ml

1.37

326

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

899

1.02

0.06

1.1

1.58

2.11

u/ml

0.24

471

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3294

32979

0.99

0.06

4.9

4.8

1.44

1.42

mmol/l

2.10

3118

31223

(40765089) Chromosome analysis panel - Blood by G-banded

131

0.92

0.05

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

801

1.02

0.05

1.4

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

100

1020

0.98

0.05

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

282

0.96

0.04

1.5

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

625

1.02

0.04

3.5

4.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

209

1.05

0.04

1.5

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

140

1.07

0.04

3.4

1.17

1.30

0.16

140

(3027923) C peptide [Moles/volume] in Serum or Plasma

221

0.95

0.04

1.6

1.5

1.77

1.31

nmol/l

0.64

166

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

531

0.98

0.03

1.5

53.61

59.79

ug/l

0.73

531

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

808

1.02

0.02

1.4

1.5

1.08

1.12

ratio

0.17

480

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

579

1.02

0.02

1.0

1.1

0.03

0.24

u/ml

2.56

177

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3144

31461

1.00

0.02

4.3

4.2

1.31

1.32

mmol/l

0.49

2961

29584

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

809

1.01

0.02

1.4

1.5

1.21

1.19

ratio

0.05

483

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

809

1.01

0.02

1.4

1.5

0.98

0.95

ratio

0.41

481

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

631

1.01

0.01

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

749

0.99

0.01

1.0

1.1

2.71

1.63

u/ml

0.42

365

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

452

1.02

0.01

1.1

—

(3039000) Anion gap in Blood by calculation

662

1.01

0.01

7.3

7.9

10.84

11.48

mmol/l

1.04

595

(3020874) Milk IgE Ab [Units/volume] in Serum

243

1.03

0.01

1.0

0.20

2.69

u/ml

1.09

(40768800) Prostate Pathology biopsy report

653

1.01

0.01

1.2

—

(3018572) Chloride [Moles/volume] in Blood

663

1.01

0.01

7.3

7.9

105.08

105.26

mmol/l

0.14

596

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

104

1.06

0.01

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

166

0.96

0.00

2.1

2.4

—

26.94

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

196

0.97

0.00

5.3

7.2

23.36

176.91

ug/l

—

131

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

182

0.99

0.00

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

175

0.97

0.00

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

285

0.98

0.00

1.2

100.46

109.51

pmol/l

0.59

285

(3051611) Lipemic interference index of Serum or Plasma

295

1.02

0.00

3.3

12.67

13.06

index

0.08

185

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

171

1712

1.00

0.00

3.9

3.1

0.67

0.61

0.99

171

1701

(3003888) Timothy IgE Ab [Units/volume] in Serum

785

0.99

0.00

1.0

1.1

4.32

4.80

u/ml

0.08

416

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

129

1.01

0.00

1.8

2.8

0.61

0.62

mmol/l

0.19

129

(3045683) HLA typing for celiac disease panel - Blood or Tissue

221

1.00

0.00

1.0

—

(3011985) Renin [Units/volume] in Plasma

499

1.00

0.00

1.4

1.5

34.22

75.78

mu/l

1.68

455

(3023430) Cat dander IgE Ab [Units/volume] in Serum

619

1.00

0.00

1.0

1.1

3.20

4.46

u/ml

0.46

269

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.04

0.00

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

323

0.99

0.00

1.4

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.85

0.00

1.0

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1150.50

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2800.00

—

(3028717) Thiamine [Mass/volume] in Blood

1.02

-0.00

1.2

1.3

65.00

65.92

ug/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.96

-0.00

1.3

1.0

44.19

43.69

iu/ml

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.94

-0.00

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.94

-0.00

1.4

1.3

—

7.15

—

(40758292) HTLV I+II Ab panel - Serum

1.00

-0.00

1.3

1.4

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

210.56

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.00

-0.00

1.1

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.4

—

2.34

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.2

—

4.63

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

42.73

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: M13_ANKYLOSPON_ICD10 – Ankylosing spondylitis, ICD10

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ankylosing spondylitis, ICD10

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Ankylosing spondylitis, ICD10 (M13_ANKYLOSPON_ICD10)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints